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Ejaculated mammalian sperm must reside within the female 
reproductive tract for a finite period of time before acquiring the ability to 
fertilize an oocyte.  The complex biochemical and physiological changes that 
occur during this process are collectively termed „capacitation‟.  Capacitation 
comprises the molecular events that prepare the sperm for acrosomal 
exocytosis and a change in the pattern of flagellar motility called 
hyperactivation.  Both of these processes are required for fertilization. 
In several domestic and laboratory species, as well as in humans, these 
events can be recapitulated in the laboratory by incubating sperm in a defined 
medium.  Two in vitro markers of capacitation include time dependent 
increases in protein tyrosine phosphorylation and high rates of agonist-
induced acrosomal exocytosis.  In contrast to other species, capacitation of 
stallion sperm has been extremely difficult to achieve with inconsistent results 
reported between and within laboratories.  Moreover, despite numerous 
attempts, only two foals have ever been produced via in vitro fertilization (IVF) 
technology.  Evidence suggests that this is ultimately due to the inability to 
appropriately capacitate stallion sperm in the laboratory. Therefore, the objectives of this research were to define and 
characterize: 1) the incubation conditions that supported capacitation of 
stallion sperm, as evidenced by increases in protein tyrosine phosphorylation 
and agonist-induced acrosomal exocytosis; 2) the molecular pathways 
involved in both of these capacitation-dependent events; 3) the motion 
parameters associated with hyperactivated motility; and 4) the incubation 
conditions that supported successful in vitro fertilization of mare oocytes. 
We determined that incubation of stallion sperm in modified Whitten‟s 
containing 25 mM sodium bicarbonate and 7 mg/ml BSA supported significant 
time-dependent increases in protein tyrosine phosphorylation and significant 
percentages of progesterone-induced acrosomal exocytosis.  We also 
demonstrated that the serine/threonine kinase protein kinase A (PKA) plays a 
critical role in the protein tyrosine phosphorylation pathway and that the 
guanine nucleotide exchange factor EPAC plays a role in acrosomal 
exocytosis.  Moreover, by characterizing the motion parameters associated 
with procaine-induced hyperactivation in stallion sperm in juxtaposition with 
our capacitating conditions, we were able to achieve 60.7% in vitro fertilization 
rates of mare oocytes (0-30% previously reported).   
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CHAPTER 1 
LITERATURE REVIEW: CURRENT UNDERSTANDING OF SPERM 
CAPACITATION AND THE STATE OF IN VITRO FERTILIZATION IN THE 
HORSE 
 
INTRODUCTION 
  When mammalian sperm are first ejaculated, they are fertilization 
incompetent.  They must reside within the female reproductive tract for a finite 
period of time before they acquire the ability to fertilize an oocyte [1].  The 
complex biochemical, physiological and cellular changes that occur during this 
process are collectively termed „capacitation‟.  The concept that sperm must 
undergo a maturational process within the female reproductive tract to acquire 
the ability to fertilize an oocyte was proposed by both Austin and Chang in 
1952 [2-4] and with this discovery came the advent of in vitro fertilization (IVF).   
The molecular events involved in capacitation prepare the sperm for 
acrosomal exocytosis and lead to a change in the pattern of flagellar motility.  In 
several species this can be recapitulated in the laboratory by incubating sperm 
in a defined medium; in contrast to other species, capacitation of sperm in the 
horse has been extremely difficult.  This is evidenced by the inability to achieve 
in vitro markers of capacitation.  For example, only low levels of protein tyrosine 
phosphorylation [5, 6] and poor acrosomal exocytosis percentages [7-10] in 
addition to very low rates of homologous IVF have been reported in this species 
[11-17].  Moreover, despite numerous attempts, IVF has only produced two foals 
[18].  Evidence suggests that all of these deficiencies are ultimately due to the 
inability to appropriately capacitate stallion sperm in the laboratory.  
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This chapter, therefore, reviews the current understanding of stallion 
sperm capacitation and IVF in this species based on the numerous previous 
attempts at these in vitro techniques. 
 
CAPACITATION-DEPENDENT PROTEIN TYROSINE PHOSPHORYLATION 
Although the molecular and biochemical changes leading to sperm 
capacitation are still under investigation, it has been shown that this process is 
associated with changes in sperm plasma membrane fluidity, intracellular ion 
concentrations, metabolism and motility [19-26].  Changes in membrane fluidity 
are postulated to occur as a result of sterol efflux from the plasma membrane; in 
this regard BSA can be used as a sterol acceptor during in vitro capacitation 
[27-29]. These changes then impact enzymatic function and/or ion transport.  
For example, calcium and bicarbonate enter the cell and activate soluble 
adenylyl cyclase (sAC or SACY), amongst other functions, with a resulting 
increase in intracellular cAMP levels.  Altogether, these events lead to an 
increase in the activity of the serine/threonine kinase, protein kinase A (PKA). 
Through a series of intermediates and pathways that have yet to be identified, 
activation of PKA is transduced into a series of protein tyrosine phosphorylation 
events (Figure 1.1) [19, 30].   
While this is presently the accepted pathway leading to protein tyrosine 
phosphorylation during sperm capacitation, the discovery of another cAMP-
regulated downstream regulator may profoundly change the previous 
assumptions of cAMP signaling.  The recently discovered family of guanine 
nucleotide exchange factors, called EPAC, mediate signal transduction 
pathways via the second messenger cAMP through PKA-independent 
pathways.  There are two known isoforms of EPAC (EPAC1 and EPAC2).   
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There is currently no membrane permeable antagonist for EPAC [31]; however, 
the development of EPAC-selective cAMP analogues that do not activate PKA 
has enabled the discovery of novel PKA-independent mediated pathways.  
Studies in somatic cells indicate that EPAC is involved in ion channel function, 
intracellular calcium signaling, ion transport activity, and exocytosis [32].  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. Postulated pathways leading to capacitation-dependent increases 
in protein tyrosine phosphorylation. BSA: bovine serum albumin; HCO3-: 
sodium bicarbonate; sAC: soluble adenylyl cyclase; PDE: phosphodiesterase; 
PKA: protein kinase A; PTK: protein tyrosine kinases; AKAP: A-kinase 
anchoring protein; Ptyr-Ptase: protein tyrosine phosphatases.  
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Additionally, in somatic cells and in mouse sperm, activation of EPAC 
with the cAMP analogue 8pCPT results in the direct downstream activation of 
RAP1 [33, 34], and in some cell types, this is followed by ERK1/2 activation [35].  
RAP1 activates the Map Kinase (MAPK) family of proteins, including ERK1/2, 
which are known to be present in mammalian sperm [35, 36].   
Interestingly, EPAC1 has been recently identified in ejaculated human 
and epididymal mouse sperm [34, 37] and EPAC2 has been identified in mouse 
spermatogenic cells [38].  Given the importance of the aforementioned signal 
transduction pathways in sperm capacitation, it is important to re-visit the 
regulation of these pathways, which were previously attributed to PKA-mediated 
events. 
In species other than the horse, protein tyrosine phosphorylation has 
been correlated with capacitation and thus the ability of sperm to undergo 
acrosomal exocytosis [28, 30] and/or to fertilize an oocyte in vitro [19].  If this 
hallmark of capacitation is inhibited, sperm do not undergo acrosomal 
exocytosis and are unable to fertilize [27, 39].  In the stallion, unlike all other 
species studied thus far [40-42], incubation conditions that support the time-
dependent increases in protein tyrosine phosphorylation, and presumably sperm 
capacitation have not been defined.    
Media reported in the literature to capacitate stallion sperm include sperm 
TALP and Biggers, Whitten, and Whittingham (BWW) [5, 43].  Sperm TALP is 
used for sperm capacitation and IVF in the bovine species, is a HEPES buffered 
medium, and contains lactate and pyruvate as energy sources (glucose inhibits 
capacitation in this species) [40].  Biggers, Whitten, and Whittingham is used for 
capacitation and IVF with human sperm, is also a HEPES buffered medium, and 
contains lactate, pyruvate and glucose as energy sources.  Despite the fact that  
  5 
these media are used with great success in their respective species, they do not 
support stallion sperm capacitation.  This is exemplified by the fact that tyrosine 
phosphorylation in stallion sperm has only been achieved in medium 
supplemented with reagents that pharmacologically raise intracellular cAMP 
levels, such as dibutyryl cAMP (dbcAMP) and phosphodiesterase inhibitors (e.g. 
caffeine), or reactive oxygen species [5, 44, 45].  Use of such chemicals 
bypasses signaling pathways in response to external stimuli, membrane 
changes, and the activation of downstream effectors, and as such, is not 
considered physiological. 
Both Sperm TALP and BWW were adopted from protocols of other 
species without any investigation into the specific physiological or metabolic 
requirements for stallion sperm.  As such, our understanding of the specific 
requirements for stallion sperm capacitation and its associated pathways are 
vastly lacking.  
 
CAPACITATION-DEPENDENT ACROSOMAL EXOCYTOSIS 
  Sperm of all mammalian species contain a secretory vesicle called the 
acrosome that forms a cap over the anterior portion of the sperm head.  The 
proteolytic enzymes contained within the acrosome are released during the 
early interaction between a capacitated sperm and an oocyte through a process 
called acrosomal exocytosis.  This is an irreversible calcium-dependent event, 
which enables the sperm to penetrate through the zona pellucida and fuse with 
the oolemma [1].  Acrosomal exocytosis is therefore required for successful 
fertilization, and as such, is used as an in vitro marker for capacitation.   
  The molecular changes that occur during capacitation, including protein 
tyrosine phosphorylation, are required in order for a sperm to undergo  
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acrosomal exocytosis upon the proper stimulation.  In vivo, this includes contact 
with the zona pellucida and/or progesterone stimulation; in vitro, progesterone is 
also used, as well as the „non-physiological‟ inducer calcium ionophore.  
Because the incubation conditions used to capacitate stallion sperm have not 
been ideal (as described above attempts to induce acrosomal exocytosis in 
stallion sperm incubated with agonists such as porcine zona pellucida, 
progesterone, heparin and calcium ionophore [7-9, 18, 46, 47], have resulted in 
variable and less than ideal results when compared to those reported in other 
species [19, 28, 48], with percentages ranging from 10 - 26% [10, 46]. 
Christensen et al. reported acrosomal exocytosis percentages as high as 71.8% 
after a 4 h incubation and subsequent exposure to heparin. The viability of 
sperm that was reported, as determined propidium iodide staining, however, 
was identical at 71.8% [7].  These identical percentages indicate that all viable 
sperm, and only the viable sperm, underwent acrosomal exocytosis, leading one 
to question the reliability of these results (some sperm will undergo spontaneous 
exocytosis upon cell death).  In contrast, based on studies in other mammalian 
species, it is generally accepted that only ~ 50% of sperm in a population will be 
able to undergo agonist-induced exocytosis [49]. 
  A key component in the regulation of acrosomal exocytosis is sperm 
plasma membrane hyperpolarization.  Hyperpolarization, which has been 
demonstrated to occur during capacitation, is required for fertility [50] and in the 
mouse, represents a change in membrane potential from ~ -30 mV to ~ -60 mV 
[50].  Currently, cAMP is believed to play a role in hyperpolarization of the sperm 
plasma membrane through a PKA-mediated pathway [50].  The current model 
involves increases in intracellular cAMP, the activation of PKA, followed by 
phosphorylation of the cystic fibrosis transmembrane conductor (CFTR).   
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Activation of CFTR allows the influx of negatively charged Cl
- ions as well as the 
inhibition of the constitutively active epithelial sodium channels (ENaC), thus 
preventing the influx of Na
+ [50].  It has also been demonstrated that the 
capacitation-associated increase in intracellular pH activates K
+
ATP channels, 
also contributing to membrane hyperpolarization [51].  The resting and 
hyperpolarized membrane potentials of non-capacitated and capacitated stallion 
sperm have not been reported. 
  Evidence suggests that when capacitated-hyperpolarized spermatozoa 
come in contact with the oocyte‟s zona pellucida, a rapid depolarization of the 
plasma membrane occurs, allowing an influx of calcium through low voltage-
activated channels [25, 52].  These channels remain in the inactivated state for 
as long as the sperm remain depolarized (i.e. non-capacitated), preventing 
premature acrosomal exocytosis [52].  Following capacitation-induced 
hyperpolarization, however, these channels switch to a closed state, becoming 
available for activation following the zona pellucida-induced depolarization. 
In cerebellar neurons, the activation of EPAC with 8pCPT has been 
demonstrated to induce hyperpolarization [36]; however, in various other 
excitable and non-excitable somatic cells, EPAC activation has been observed 
to have effects on above mentioned ion channels such that a depolarization of 
the plasma membrane would be expected.  For example, in pancreatic beta 
cells, Kang et al. observed an EPAC-mediated inhibition of K
+
ATP channels [53]; 
in rat pulmonary epithelial cells EPAC activation increased the channel open 
probability of ENaC [54]; and in rat hepatocytes, it stimulated an outwardly 
rectifying Cl
- current [55].   
In addition, activation of EPAC is believed to mediate calcium 
mobilization through cAMP in three hypothesized ways: 1) by interacting directly  
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with inositol 1,4,5-trisphosphate receptors (IP3R) to release calcium from 
intracellular stores; 2) by acting through RAP GTPases to activate protein 
kinases that phosphorylate and regulate the function of calcium release; and/or 
3) by stimulation of RAP GTPases that activate phospholipase C (PLC), 
generating IP3 [32].   
Recent evidence from Branham et al. shows that activation of EPAC in 
permeabilized-human spermatozoa induces acrosomal exocytosis in a calcium-
dependent manner [37].  Currently, there are no reports investigating the effect 
of EPAC activation in intact-mammalian sperm, or its effect on stallion sperm 
physiology. 
 
HYPERACTIVATION 
Penetration of the outer vestments of the oocyte at fertilization also 
requires a change in the pattern of sperm motility that has been termed 
hyperactivation [24, 56, 57].  The acquisition of hyperactivated sperm motility 
has been observed within the oviducts of mammals at the time of fertilization 
[58-60] and is required for zona pellucida penetration [24, 25].  It is also believed 
to play a role in the ability of sperm to detach from the oviductal wall [60], 
navigate the labyrinthine environment of the oviduct [61], and penetrate the 
viscous mucoid environment encountered in the female reproductive tract [60, 
62] (for review see [63]). The precise motility pattern that defines hyperactivation 
is species-specific; however, it is generally characterized by increases in lateral 
head displacement, flagellar bend amplitude and beat asymmetry [25, 56, 64].  
Capacitation and hyperactivation are often linked together in the 
continuum of changes that a sperm must undergo to fertilize an oocyte; 
moreover, both processes require calcium, bicarbonate and the activation of  
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cAMP synthesis [19, 27, 65, 66]. However, the pathways that regulate these 
events are considered separable and independent [63, 67, 68]. This has been 
demonstrated in Catsper null mutant mice whereby disruption of any CATSPER 
proteins (which form alkaline activated calcium channels) resulted in normal 
sperm production, protein tyrosine phosphorylation patterns and rates of 
acrosomal exocytosis; however, the Catsper null sperm failed to hyperactivate, 
could not penetrate zona-intact oocytes and as a consequence these mice were 
infertile [24, 57].  In addition, in vitro-incubated bovine sperm that exhibit 
markers of capacitation do not hyperactivate; however, hyperactivation can be 
exogenously induced in capacitated as well as non-capacitated sperm by 
exposure to procaine [68], further supporting the hypothesis that capacitation 
and hyperactivation are independent processes. Although the exact mechanism 
by which procaine induces hyperactivation is not known, it is believed to 
stimulate calcium influx by increasing the permeability of the plasma membrane 
to calcium [67].  
Although Rathi et al. [43] designated certain motility parameters (as 
measured by computer assisted semen analysis (CASA)) as indicative of 
hyperactivated motility in stallion sperm, none of the treatments tested in that 
study significantly affected the proportions of sperm showing these patterns.  In 
fact, after 5 h of incubation under capacitating conditions, only 35% of sperm 
were motile, of which 5.3% were considered hyperactivated as defined by a 
curvilinear velocity (VCL) greater than 180  m/sec and an amplitude of lateral 
head displacement (ALH) greater than 12  m.  Incubation in the presence of 1 
M calcium ionophore to induce hyperactivation had a negative effect on motility 
such that no sperm were motile after 3.5 h of incubation [43].  Thus, the pattern 
of hyperactivation and its associated measures of motility have not been defined  
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in stallion sperm.  
 
IN VITRO FERTILIZATION IN THE HORSE 
Only two foals have ever been produced using in vitro fertilization (IVF) 
technology [18] despite decades of work addressing this topic. Though 
numerous groups have attempted to replicate this result, there has been limited 
critical investigation into the requirements for horse IVF protocols since the first 
report was published more than 15 years ago [12-15, 69, 70].  Protocols used 
were typically derived from bovine IVF protocols, including incubating sperm in 
the presence of calcium ionophore, heparin or mixed semen samples in which 
sperm from multiple stallions were incubated together [69], without any 
investigation into the specific incubation conditions required for this species [71].  
Fertilization rates have ranged from 0% to 33% [12] and these results were 
inconsistent even between studies performed by the same laboratories [13-15]. 
Protocols with the most success are those in which sperm were 
incubated in the presence of calcium ionophore, which artificially increases 
intracellular calcium levels leading to acrosomal exocytosis; fertilization rates of 
untreated sperm are essentially 0% [12, 18].  Other reports have included 
partially or completely removing the zona pellucida and zona drilling.  These 
techniques resulted in high rates of polyspermic fertilization, upwards of 65% 
[70].   
It appears that the failure of the sperm to penetrate the zona pellucida is 
not due to premature hardening of the zona (i.e. cortical granule release) since 
IVF was equally unsuccessful with in vivo-matured and in vitro-matured mare 
oocytes [18], and oviductal transfer of in vitro-matured oocytes to inseminated 
mares results in fertilization rates comparable to those obtained by natural  
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mating (77%) [11].  Therefore, it is likely that the low sperm penetration rates 
observed in IVF studies have stemmed from the inability to appropriately 
capacitate and/or hyperactivate stallion sperm in the laboratory.  Altogether, it is 
clear from the information presented that a critical study into the molecular 
pathways supporting stallion sperm capacitation, and ultimately IVF, is required. 
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CHAPTER 2 
A DEFINED MEDIUM SUPPORTS CHANGES CONSISTENT WITH 
CAPACITATION IN STALLION SPERM AS EVIDENCED BY INCREASES IN 
PROTEIN TYROSINE PHOSPHORYLATION AND HIGH RATES OF 
ACROSOMAL EXOCYTOSIS
1 
 
ABSTRACT   
Efficient in vitro capacitation of stallion sperm has not yet been achieved as 
suggested by low sperm penetration rates reported in in vitro fertilization (IVF) 
studies.  Our objectives were to evaluate defined incubation conditions that would 
support changes consistent with capacitation in stallion sperm.  Protein tyrosine 
phosphorylation events and the ability of sperm to undergo acrosomal exocytosis 
under various incubation conditions were used as endpoints for capacitation. Sperm 
incubated 4-6 h in modified Whitten‟s (MW) with the addition of 25 mM NaHCO3 
and 7 mg/ml BSA (capacitating medium) yielded high rates of protein tyrosine 
phosphorylation. Either HCO3
- or BSA was required to support these changes, with 
the combination of both providing the most intense results.  When a membrane 
permeable form of cAMP and a phosphodiesterase inhibitor (IBMX) were added to 
MW in the absence of HCO3
- and BSA, the tyrosine phosphorylation results 
obtained in our capacitating conditions could not be replicated, suggesting either 
effects apart from cAMP were responsible for tyrosine phosphorylation, or that 
stallion sperm might respond differently to these reagents as compared to sperm 
from other mammals.  Sperm incubation in capacitating conditions was also 
associated with high percentages (P≤0.001) of acrosomal exocytosis upon 
                                                        
1  McPartlin, LA, Littell, J, Mark, E, Nelson, JL, Travis, AJ, Bedford-Guaus, SJ. 
Theriogenology. 2008 Mar 15;69(5):639-50. License # 2238310704841   
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exposure to progesterone (44.6%) or calcium ionophore (51.6%), as compared to 
sperm incubated in medium devoid of BSA and NaHCO3. Our results are novel in 
that we report protein tyrosine phosphorylation in stallion sperm incubated in 
defined conditions coupled with significant percentages of acrosome reacted 
sperm. The continuation of these studies might help elucidate the conditions and 
pathways supporting sperm capacitation in the horse.  
 
INTRODUCTION 
Ejaculated mammalian spermatozoa are not immediately able to fertilize 
an oocyte but acquire this ability during transit within the female reproductive 
tract [1].  The process that renders sperm fertilization-competent is termed 
“capacitation” and in several species it can be mimicked in the laboratory by 
incubating sperm in defined media and conditions which vary slightly between 
species [2-5].  Media requirements for in vitro capacitation usually include a 
sterol acceptor (typically BSA), bicarbonate, calcium and energy sources in all 
species studied to date.   
Although the molecular and biochemical changes leading to sperm 
capacitation are still under investigation, it has been shown that this process is 
associated with changes in sperm plasma membrane fluidity, intracellular ion 
concentrations, metabolism and motility [4,6-12]. Changes in membrane fluidity 
are postulated to occur as a result of sterol efflux from the plasma membrane; in 
this regard BSA can be used as a sterol acceptor during in vitro capacitation 
[13-15]. Changes in membrane conformation then impact enzymatic function 
and/or ion transport.  For example, calcium and bicarbonate enter the cell and 
activate soluble adenylyl cyclase (sAC), amongst other functions, with a 
resulting increase in intracellular cAMP levels.  Altogether, these events lead to  
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an increase in protein kinase A (PKA) activity, which is then transduced into a 
series of protein tyrosine phosphorylation events [4,16].   
In species other than the horse, protein tyrosine phosphorylation has 
been correlated with capacitation and thus the ability of sperm to undergo 
acrosomal exocytosis [15,16] and/or to fertilize an oocyte in vitro [4].  However, 
in the stallion, evidence for tyrosine phosphorylation of sperm proteins has only 
been reported for samples incubated in media supplemented with reagents that 
increase cAMP levels, such as dibutyryl cAMP (dbcAMP) and 
phosphodiesterase inhibitors (i.e. caffeine), or reactive oxygen species [17,18].  
Use of such chemicals bypasses signaling pathways in response to external 
stimuli, membrane changes, and the activation of downstream effectors.  
Additionally, attempts to induce the acrosome reaction in stallion sperm 
incubated with agonists such as porcine zona pellucida, progesterone, heparin 
and calcium ionophore [19-24], amongst others, have resulted in variable and 
generally less than ideal results when compared to those reported in other 
species [4,15,25].  Moreover, only two foals have ever been produced using in 
vitro fertilization (IVF) technology [19] and these results have not been 
repeatable as numerous attempts at IVF have resulted in low sperm penetration 
rates [26-30].  We suspect that this stems from the inability to capacitate horse 
sperm in the laboratory appropriately.  Therefore, the objective of this study was 
to evaluate critically in vitro incubation conditions supporting protein tyrosine 
phosphorylation and acrosomal exocytosis as endpoints for stallion sperm 
capacitation.   
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MATERIALS AND METHODS 
Chemicals and Reagents.  Four-Bromo-Calcium Ionophore A23187 was 
obtained from Calbiochem (San Diego, CA, USA).  Tween 20 was purchased 
from BioRad (Hercules, CA, USA).  Anti-phosphotyrosine monoclonal antibody 
(mAB), 4G10, was purchased from Upstate Biotechnology (Lake Placid, NY, 
USA).  PNA-Alexa 488 was purchased from Invitrogen Corp. (Carlsbad, CA, 
USA).  All other chemicals were purchased from Sigma Chemical Company (St. 
Louis, MO, USA). 
Culture Media.  Three different media were initially tested for our 
experiments to determine which supported both the best longevity of sperm 
motility and the highest levels of protein tyrosine phosphorylation.  Media used 
included: Sperm TALP (spTALP; 100 mM NaCl, 3.10 mM KCl, 0.3 mM 
NaH2PO4, 21.6 mM sodium lactate, 2.0 mM CaCl2, 0.4 mM MgCl2, 10.0 mM 
HEPES, and 1.0 mM pyruvate) [31];  Biggers, Whitten, and Whittingham (BWW; 
91.06 mM NaCl, 4.78 mM KCl, 2.44 mM MgSO4, 1.17 mM KPO4, 21.0 mM 
HEPES, 5.55 mM glucose (anhydrous), 0.25 mM sodium pyruvate, 1.71 mM 
lactic acid hemicalcium salt and 21.55 mM sodium lactate) [17]; and modified 
Whitten‟s (MW; 100 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 5.5 mM glucose 
(anhydrous), 22 mM HEPES, 4.8 mM lactic acid hemicalcium salt and 1.0 mM 
pyruvic acid) [12].  Sperm TALP is typically used to capacitate bovine sperm [32] 
and has been widely used in attempts to capacitate stallion sperm as reported in 
the literature [22,33,34]; BWW is a human IVF medium and has also been used 
for stallion sperm capacitation [17,35]; and MW is a murine sperm capacitation 
medium [11]. 
Negative control base medium was always devoid of BSA and HCO3
- and 
served both as transport and non-capacitating medium.  Capacitating conditions  
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were optimized during these experiments, and unless otherwise indicated, 
capacitation was achieved by adding 25 mM NaHCO3 and 7 mg/ml BSA to each 
NC base media.  For all media tested, the final pH was brought to 7.25.  
Semen Collection and Preparation. Semen was collected with an artificial 
vagina from five adult stallions of proven fertility in compliance with IACUC 
guidelines.  After visual evaluation of sperm motility under light microscopy 
(200x) on a heated stage and assessment of sperm concentration using a 534B 
MOD1 Densimeter (Animal Reproduction Systems; Chino, CA, USA), the sperm 
rich fraction was diluted 2:1 (vol:vol) in the appropriate pre-warmed non-
capacitating medium and transported to the laboratory at 37 °C for immediate 
processing.  Samples were centrifuged in 15-ml conical tubes at 100 x g for 1 
min (37 °C) to remove particulate matter and dead sperm.  The supernatant was 
then transferred to a 14-ml round bottom centrifuge tube and centrifuged at 650 
x g for 5 min (37 °C), and the resultant loosely-packed sperm pellet was 
resuspended in the appropriate media to a final concentration of 10 x 10
6 
sperm/ml.  Samples were incubated in 500 μL aliquots in polyvinyl alcohol 
coated 5-ml round bottom tubes [36] at 37 
oC in a humidified air atmosphere, 
unless otherwise stated.   
For experiments in which it was necessary to prevent the formation of 
HCO3
- from CO2 in surrounding air or trapped within the medium, sperm were 
incubated under a nitrogen atmosphere.  For this purpose, the medium was 
saturated by bubbling it with nitrogen gas for at least 1 min.  Thereafter, all pre-
filled tubes were gassed with nitrogen to displace any air; great care was taken 
to minimize the time of air exposure, and tubes were immediately capped tightly 
for incubation.  
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Sperm Processing.  At different time-points following incubation, percent 
total and progressive motility was assessed either subjectively using light 
microscopy on a heated stage (200x) or by using computer assisted semen 
analysis (CASA; Hamilton Thorne Bioscience, Beverly, MA, USA), depending on 
individual experiments.  Samples were then transferred into siliconized 
microcentrifuge tubes containing 5 µL of sodium ortho-vanadate (2 mM) in 
phosphate buffered saline (PBS) to inhibit endogenous phosphatases.  Samples 
were then processed for SDS-PAGE as previously described [15].  Briefly, 
samples were centrifuged at 2,000 x g for 2 min at 4 °C, washed in 1.5 ml of 
PBS, and the final pellet was resuspended in 30 µL PBS plus 8 µL of 5X sample 
buffer [37] containing DTT (40mM), and boiled for 5 min.  The samples were 
then centrifuged at 7500 x g for 2 min at 4 °C and subjected to SDS-PAGE. 
SDS-PAGE and Immunoblotting.  The total volume of extract 
corresponding to equal numbers of sperm in each sample (5 x 10
6 sperm) was 
loaded on 10% SDS gels.  Separated proteins were blotted onto Immobilon P 
membranes (Millipore, Inc.; Billerica, MA, USA), Ponceau stained to confirm 
even protein load and blocked for 1 h with 1:10 (vol:vol) dilution of cold water 
fish skin gelatin in TBS with 1% Tween 20.  This solution was used for all 
subsequent antibody incubations and washes.  Immunodetection of proteins 
was performed at room temperature using a monoclonal antibody against 
phosphotyrosine at a 1:10,000 dilution for 1 h, washed extensively (1 h, four 
exchanges) and incubated for 30 min with goat anti-mouse horseradish 
peroxidase-coupled IgG.  After extensive washing of blots, immunoreactivity 
was visualized using enhanced chemiluminescence detection with an ECL kit 
(Amhersham Corp.; Piscataway, NJ, USA) according to the manufacturer‟s  
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directions.  Experiments shown are representative of at least three replicates 
with at least three different stallions tested for each experiment. 
For densitometry analysis, three immunoblots from three different 
stallions were scanned and the relative intensity of two proteins (~ 150 kD and ~ 
114 kD) was determined within each experiment using a gel-scanning macro for 
ImageJ software (http://rsb.info.nih.gov/ij/index.html).   
Acrosome Reaction Assay.  At 0 and 6 h of incubation, sperm samples in 
different media conditions were further incubated for 30 min with 3.2 μM 
progesterone (P4), 5 μM calcium ionophore A23187 (CaI), or an equal volume of 
vehicle control (2.5 μl DMSO; 0.5% vol:vol ) to induce the acrosome reaction.  
At the end of each incubation period the percentages of total and progressively 
motile sperm were assessed with light microscopy on a heated stage (200x). 
Acrosomal status of non-fixed, non-permeabilized, live sperm was assessed 
with the addition of PNA-Alexa 488 (final concentration 0.024 mg/ml) [22] to a 
125 μL aliquot of the sperm suspension; 100 μL was then pipetted onto a glass 
slide on a heated stage.  Sperm were allowed to settle for 1 min and excess 
medium was removed by pipetting.  The sample was then gently washed with 
warm PBS, coversliped and scored (600x) for acrosomal status using an upright 
fluorescent Zeiss Imager ZI microscope with Green Fluorescent Protein (GFP) 
filters.  One hundred morphologically normal sperm were counted per slide and 
evaluation was performed blindly of treatment status.  
Statistical Analysis.  Statistical analysis was performed using SigmaStat 
software (San Jose, CA, USA). Data for percent motility were analyzed by 
repeated measures ANOVA.  Statistical analysis for the acrosome induction 
experiment was performed by repeated measures four-way ANOVA for each of 
the three possible outcomes (intact, intermediate, reacted) with all stallion,  
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treatment, time and inducing agent, as well as their interactions, as main effects. 
Data for relative densitometry for each of two immunoblotted protein bands (~ 
150 kD and ~ 114 kD) was analyzed by two-way ANOVA, with both treatment 
and incubation time, as well as their interaction, as main effects.  When 
significant differences were detected (P<0.05) the Student-Newman-Keuls test 
was applied to assess all pairwise multiple comparisons.  
 
RESULTS 
Media Comparison 
Our first objective was to identify an incubation medium that would 
support sperm motility for the duration of the 6 h incubation period while yielding 
time-dependent increases in protein tyrosine phosphorylation.  For this purpose 
we compared three different media: spTALP, BWW and MW, using four different 
stallions during both the breeding season and the winter months.  While all three 
media yielded some increase in protein tyrosine phosphorylation in a time-
dependent manner, MW most consistently supported marked levels of tyrosine 
phosphorylation independent of stallion and season.  As shown in Table 2.1, 
MW also supported the highest percentage of total and progressively motile 
sperm, with differences appearing at 4 h and continuing throughout the 6 h 
incubation when compared to sp-TALP (P<0.03).  For these reasons, MW was 
chosen for all subsequent experiments.  Shown in Figure 2.1 is a representative 
immunoblot of the tyrosine phosphorylation levels achieved under capacitating 
versus non-capacitating conditions with MW. Protein tyrosine phosphorylation 
levels differed (P<0.01) between the two incubation conditions for both protein 
bands analyzed (~ 150 kD and ~ 114 kD), both at 2 and 4 h.  
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Effects of BSA and NaHCO3 in the Capacitation Medium 
In all species studied to date, sperm must be capacitated in a medium 
containing a sterol acceptor, typically BSA, bicarbonate and calcium 
[2,3,13,38,39].  Therefore, as a first step, we incubated sperm in medium 
containing 1, 5, 7 and 10 mg/ml BSA, in the presence of 25 mM HCO3
-, for 0, 2 
and 4 h to establish the optimal concentration requirement of BSA in regards to 
tyrosine phosphorylation.  Sperm incubated in medium devoid of BSA and 
NaHCO3 served as our negative control.  All concentrations of BSA tested 
supported higher levels of tyrosine phosphorylation than the non-capacitating 
condition (Figure 2.2; P<0.05) for the protein band at ~ 150 kD. However, 
concentrations of BSA between 5-10 mg/ml were superior to 0-1 mg/ml at 
supporting sperm longevity of motility (data not shown).  Based on these results 
we chose the medium range concentration of 7 mg/ml BSA for our capacitating 
conditions thereafter.  
We then compared the individual and combined effects of BSA and 
HCO3
- for their ability to support tyrosine phosphorylation.  The concentration of 
25 mM NaHCO3 was chosen based on sperm capacitation reports from other 
large animal species [5,40].  When sperm were incubated in an air atmosphere, 
medium containing BSA but not NaHCO3 was consistently better at supporting 
both sperm motility and tyrosine phosphorylation of protein residues than the 
non-capacitating base medium (Figure 2.3A; P 0.02) for both protein bands 
analyzed. Conversely, levels of tyrosine phosphorylation did not differ (P>0.05) 
between sperm incubated in non-capacitating medium and medium containing 
NaHCO3 with no BSA. The combination of both BSA and HCO3
- (capacitating 
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Table 2.1. Total and progressive motility data for stallion sperm incubated in three different capacitating media. 
 
          t0 h           t2 h             t4 h           t6 h__  
Medium  Total *   Progressive   Total   Progressive   Total   Progressive        Total  Progressive  
spTalp   78 (3.9)  60 (8.0)     66 (4.2)   44 (6.0)     58
a
 (6.7)   40 (7.8)        41a (6.7)    26
a (6.2)  
BWW   79 (2.9)   66 (4.3)    72 (5.1)   56 (5.2)     72
a,b
(4.0)  56 (3.8)        68b (4.5)    54
b (4.0)  
MW    75 (2.6)   56 (5.8)     80 (3.1)   61 (5.5)     76
b
 (3.3)   58 (5.2)        72b (4.0)    55
b
 (3.9)  
 
a,b Within a column, means without a common superscript differed (P < 0.05). Results are means from 13 different 
experiments.  
* Data are expressed as % (S.E.M.).  
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Figure 2.1. Representative immunoblot for protein tyrosine 
phosphorylation in stallion sperm incubated in an air atmosphere at 37 C 
in modified Whitten's for 0, 2 and 4 h. Capacitation medium (C) contained 
25 mM NaHCO3 and 7 mg/ml BSA; non-capacitating medium (NC) was 
devoid of NaHCO3 and BSA. Protein bands at ~150 and ~114 kDa were 
used for statistical analysis. Densitometric analysis of these bands yielded 
differences (P < 0.05) between NC and C at both 2 and 4 h.  
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condition) yielded the highest levels of protein tyrosine phosphorylation when 
compared to all other conditions (P<0.05).  However, in an air atmosphere, CO2 
mixing with water in the medium generates carbonic acid, and therefore 
bicarbonate.  Consequently we suspected that the effectiveness of BSA alone 
might have been due to the presence of small amounts of HCO3
- forming from 
exchange with the surrounding air.  To investigate this possibility, the same 
experiment was repeated under nitrogen saturation.  When incubated under a 
nitrogen atmosphere, BSA alone did not provide an advantage over HCO3
- 
alone when compared to sperm incubated in the non-capacitating condition 
(P>0.05).  As in the previous experiment, our capacitating conditions (BSA + 
HCO3
-) provided the most intense pattern of tyrosine phosphorylation (P<0.01).     
The above findings suggested that a very small concentration of HCO3
- in 
BSA-containing medium should be sufficient to support tyrosine phosphorylation 
events in stallion sperm.  Therefore we compared medium containing 1, 5, 10 
and 25 mM NaHCO3 in the presence of 7 mg/ml BSA under a N2 atmosphere.  
Although not significant (P=0.08), as little as 1 mM HCO3
- was sufficient to 
consistently induce an increase in protein tyrosine phosphorylation (Figure 2.4). 
Over time, both 10 and 25 mM NaHCO3 supported the highest levels of protein 
tyrosine phosphorylation (P<0.05) when compared to the non-capacitating 
condition for both bands analyzed.  Furthermore, these higher concentrations of 
HCO3
- were required to promote tyrosine phosphorylation in the higher 
molecular weight proteins (75-250 kD; P<0.05).  For these reasons and because 
25 mM HCO3
- approximates the concentration present in body fluids [41], 
presumably what sperm encounter when traveling through the female‟s 
reproductive tract, the higher concentration was chosen for subsequent 
experiments.   
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Figure 2.2. Representative immunoblot for protein tyrosine 
phosphorylation in stallion sperm incubated in an air atmosphere at 
37 C in modified Whitten‟s for 0 and 4 h. Capacitation medium (C) 
contained 25 mM NaHCO3 and various concentrations (1, 5, 7 and 
10 mg/ml) of BSA; non-capacitating medium (NC) was devoid of 
NaHCO3 and BSA. Protein bands at ~150 and ~114 kDa were used 
for statistical analysis. Medium containing BSA supported higher 
levels (P < 0.05) of protein tyrosine phosphorylation when 
compared to the NC condition.  
  34 
(A) 
 
 
 
 
 
 
 
 
(B)
Figure 2.3. Representative immunoblots for protein tyrosine phosphorylation in 
stallion sperm.  Non-capacitating medium (NC) was devoid of NaHCO3 and BSA; 
the BSA lane contained 7 mg/ml BSA and no NaHCO3; the HCO lane contained 
25 mM NaHCO3 and no BSA; capacitation medium (Cap) contained 25 mM 
NaHCO3 and 7 mg/ml BSA. Protein bands at ~150 and ~114 kDa were used for 
statistical analysis. (A) Sperm were incubated in an air atmosphere at 37°C in 
modified Whitten‟s for 0 and 4 h. BSA supported higher levels of protein tyrosine 
phosphorylation than NC (P < 0.02). (B) Sperm were incubated in a N2 saturated 
atmosphere at 37°C in modified Whitten‟s for 0 and 4 h. For both immunoblots (A 
and B), Cap yielded higher levels of protein tyrosine phosphorylation than all 
other conditions (P < 0.05).  
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Evaluation of Exogenous cAMP Pathway Modulators 
Protein tyrosine phosphorylation of sperm undergoing capacitation is believed to 
occur via a cAMP-PKA-dependent pathway.  To test for a role of cAMP as a key 
mediator of tyrosine phosphorylation in stallion sperm, we compared our non-
capacitating and capacitating conditions, both with and without the addition of 1 
mM dbcAMP and 0.1 mM 3-Isobutyl-1-methylxanthine (IBMX) [4,5].  As 
expected, these reagents initially accelerated the rate of protein tyrosine 
phosphorylation in medium containing BSA and HCO3
- as compared to sperm 
incubated under our capacitating conditions (Figure 2.5; P≤0.002 at 2 h); 
however, at 4 and 6 h of incubation there were no differences (P>0.05) between 
the two conditions for both protein bands analyzed.  Notably, sperm capacitated 
in the presence of dbcAMP and IBMX had lower total motility at 6 h than sperm 
incubated in capacitating conditions without these reagents (56% vs. 73%, 
respectively; P<0.05).  Unexpectedly, sperm incubated in medium devoid of 
BSA and HCO3
- but with the addition of the cAMP agonist and 
phosphodiesterase inhibitor (lane NC
++) did not display a time-dependent 
increase in tyrosine phosphorylation when compared to our non-capacitating 
condition (P>0.05), as it has been reported to occur in other species.   
Because the addition of dbcAMP and IBMX to non-capacitating 
conditions did not support the intensity of tyrosine phosphorylation observed 
under our capacitating conditions, we predicted that the presence of either BSA 
or HCO3
-, or both, was essential to facilitate these events. To test these 
possibilities we incubated sperm in medium containing dbcAMP/IBMX in the 
presence of BSA and/or HCO3
- under a nitrogen atmosphere (Figure 2.6).  
Interestingly, when either BSA or HCO3
- was present in conjunction with 
dbcAMP and IBMX, increases in tyrosine phosphorylation levels were  
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comparable to those seen in capacitating medium with and without these 
reagents (P>0.05).  
 
 
 
Figure 2.4. Representative immunoblot for protein tyrosine phosphorylation in 
stallion sperm incubated in a N2 atmosphere at 37°C in modified Whitten‟s for 
0, 2 and 4 h.  Non-capacitating medium (NC) was devoid of NaHCO3 and 
BSA; remaining lanes contain 7 mg/ml BSA plus various concentrations of 
NaHCO3 (1, 5, 10 and 25 mM). Protein bands at ~150 kD and ~114 kD were 
used for statistical analysis. Over time, both 10 and 25 mM NaHCO3 
supported the highest levels of protein tyrosine phosphorylation (P < 0.05) 
when compared to NC for both bands analyzed.  
  37 
Figure 2.5 Representative immunoblot for protein tyrosine phosphorylation in 
stallion sperm incubated in an air atmosphere at 37°C in modified Whitten‟s 
for 0, 2, 4 and 6 h with and without the addition of cAMP modulators.  Non-
capacitating medium is devoid of both NaHCO3 and BSA (NC); non-
capacitating medium plus the addition of 1 mM dbcAMP and 0.1 mM IBMX 
(NC++); capacitation medium contains 25 mM NaHCO3 and 7 mg/ml BSA (C); 
capacitation medium plus the addition of 1 mM dbcAMP and 0.1 mM IBMX 
(C++).  Protein bands at ~150 kD and ~114 kD were used for statistical 
analysis. C and C++ were different (P   0.002) at 2 h, but not at 0, 4 or 6 h   
(P > 0.05). Over time, both C
++ and C yielded higher levels of protein tyrosine 
phosphorylation than NC and NC++ (P < 0.01).  
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Figure 2.6. Representative immunoblot for protein tyrosine phosphorylation in stallion sperm incubated in a N2 
atmosphere at 37°C in modified Whitten‟s for 0, 2, 4 and 6 h with (+) and without (-) addition of the cAMP 
modulators dbcAMP (1 mM) and IBMX (0.1 mM).  Non-capacitating medium (NC) is devoid of both NaHCO3 
and BSA; HCO lane contains 25 mM NaHCO3 and no BSA; BSA lane contains 7 mg/ml BSA and no NaHCO3; 
capacitation medium (C) contains 25 mM NaHCO3 and 7 mg/ml BSA. Protein bands at ~150 kD and ~114 kD 
were used for statistical analysis. Levels of tyrosine phosphorylation were comparable between the capacitating 
(C), BSA and HCO conditions both with and without the addition of cAMP modulators (P > 0.05). 
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Acrosome Reaction Assay  
  We next tested the ability of sperm incubated in capacitation conditions to 
undergo agonist-induced acrosomal exocytosis. To accomplish this, we exposed 
sperm previously incubated for 0 or 6 h in non-capacitating and capacitating 
conditions to a physiological concentration of progesterone, 3.2 μM [42], 5 μM 
calcium ionophore A23187, or DMSO (vehicle control) for 30 min.  Sperm were 
scored by assessing the pattern of PNA-Alexa 488 fluorescence [22] and 
classified as acrosome intact (post acrosomal fluorescence only; Figure 2.7A), 
intermediate (fluorescence on the apical ridge of acrosome; Figure 2.7B) or 
acrosome reacted (bright acrosomal fluorescence; Figure 2.7C).  At 0 h, there 
were no differences observed between media conditions or between treatments 
for any of the above classifications (P>0.05; Figure 2.8A).  After 6 h of 
incubation in capacitating medium, both progesterone and calcium ionophore 
were able to induce higher percentages (P 0.001) of acrosome reacted sperm 
(44.6 % and 51.6%, respectively) when compared with exposure to DMSO 
(15.0%; Figure 2.8B).  Conversely, there were no differences (P>0.05) in the 
percent of acrosome reacted sperm for any of the treatments when incubation (6 
h) was performed in non-capacitation medium (Figure 2.8B).  Furthermore, there 
were no significant interactions between treatment and stallion or ejaculate in 
any of the time points analyzed.   
  
 
Figure 2.7 PNA-Alexa 488 fluorescence pattern of: (A) an acrosome intact sperm 
lacking signal over the acrosomal cap; (B) an intermediately reacted sperm with 
signal restricted to the apical portion of the acrosomal cap; and (C) an acrosome 
reacted sperm with strong fluorescence over the entire acrosome.  Scale bar 
represents 5 μm. 
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Figure 2.8. Percent of three different acrosomal patterns detected by 
PNA-Alexa 488 under a fluorescent microscope at 600x.  Sperm were 
incubated in an air atmosphere at 37°C in non-capacitating (NC) or 
capacitating medium (Cap) for 0 hours (A) and 6 hours (B).  For 
acrosome reaction induction sperm were incubated for 30 min in vehicle 
control (DMSO; 2.5  l), progesterone (P4; 3.2 µM) or calcium ionophore 
A23187 (CaI; 5  M). One-hundred sperm were scored per treatment at 
each time point and the percentages of each category (acrosome intact, 
intermediate or reacted) are reported. At 0 hr (A) there were no 
significant differences in the percent of acrosome intact, intermediate or 
reacted sperm for any of the conditions (NC or Cap) or inducing agents 
(DMSO, P4 or CaI). At 6 hr (B) each of the sets of superscripts (a,b; 
a‟,b‟ or  a‟‟,b‟‟) represent differences (P   0.001) between treatments 
(NC and Cap) or acrosome reaction inducing agent (DMSO, P4 and 
CaI) for each of the three categories of sperm (intact, intermediate and 
reacted, respectively). Within incubation medium (NC or C) different 
superscripts for each of the treatments denote significant differences  
(P ≤ 0.001).  Comparison of sperm incubated for 6 h in NC versus Cap 
yielded significant differences in the rates of acrosome intact (a,b) and 
reacted (a‟‟,b‟‟) sperm for both the progesterone and calcium ionophore 
treatments but not for DMSO (P < 0.001). Within Cap, there were no 
differences (P > 0.05) in the percent of acrosome intact, intermediate or 
reacted sperm between P4 and CaI.  
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DISCUSSION 
We show for the first time that significant levels of protein tyrosine 
phosphorylation can be achieved in stallion sperm incubated under defined 
conditions, in the absence of exogenous signaling intermediates that in other 
reports have bypassed upstream signaling events [17].  In other species, the 
molecular changes we show have been correlated with capacitation as defined 
by the ability of sperm to undergo an induced acrosomal exocytosis and/or to 
fertilize oocytes in vitro [43].  The observed levels of protein tyrosine 
phosphorylation coupled with the significant rates of acrosomal exocytosis 
reported herein suggest that sperm incubated in the conditions described 
underwent molecular and membrane changes that are consistent with 
capacitation.  
In our laboratory, the medium that was best at supporting sperm motility 
coupled with the most consistent rates of protein tyrosine phosphorylation was 
modified Whitten‟s, which has been used to capacitate mouse sperm [12] and to 
support in vitro fertilization of mouse oocytes [11].  While optimizing the media 
requirements that support protein tyrosine phosphorylation, we demonstrated 
that BSA and HCO3
- are critical components for tyrosine phosphorylation in 
stallion sperm as has been shown in other species.  When the effect of each of 
these components was studied separately, we found that BSA was required to 
maintain sperm motility as well as to support an increase in protein tyrosine 
phosphorylation over time.  Additionally, when another protein source, casein, 
was substituted for BSA, motility was also maintained; however, there was no 
increase in protein tyrosine phosphorylation (data not shown).  It is worth noting 
that a very low concentration of HCO3
- (1 mM) in the presence of BSA was 
sufficient to induce an increase in protein tyrosine phosphorylation levels when  
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compared to the non-capacitating condition (Figure 2.4; P=0.08).  In fact, low 
levels of HCO3
- produced in the medium from exchange with the surrounding air 
were sufficient to induce marked changes in protein tyrosine phosphorylation 
(Figure 2.3A), suggesting that stallion sperm are more sensitive to HCO3
--
induced tyrosine phosphorylation than sperm from other species studied to date 
[2-4]. 
In order to investigate the upstream signaling pathway leading to tyrosine 
phosphorylation of stallion sperm proteins, we added dbcAMP and IBMX to our 
non-capacitating medium.  Because these chemicals are membrane permeable 
and have been shown to support increases in protein tyrosine phosphorylation 
in the absence of BSA and bicarbonate in other species [2-5,44], we anticipated 
that their addition to our non-capacitating medium would induce phosphorylation 
levels comparable to those observed in our capacitating conditions.  
Unexpectedly, they were unable to produce these changes in the absence of 
BSA and/or HCO3
-.  Although Pommer et al. [17] showed increases in protein 
tyrosine phosphorylation when stallion sperm were incubated in the presence of 
dbcAMP and caffeine, the incubation medium used in this study always 
contained BSA.  That study did not investigate the role of the cAMP modulators 
in the absence of a sterol acceptor, which could be critical in elucidating the 
specific requirements and pathways involved in stallion sperm capacitation.   
Conceivably, changes in membrane fluidity and/or phospholipid 
scrambling induced by BSA and/or HCO3
- might be playing key roles that can 
not be overcome by the use of the cAMP modulators alone.  For example, 
bicarbonate enters the cell via a Na/HCO3
- co-transporter [45] causing a rapid 
increase in plasma membrane disorder [33,46], most likely by inducing 
phospholipid scrambling [6,47].  This re-organization of the sperm plasma  
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membrane might have downstream effects similar to BSA, perhaps by activating 
the sAC-cAMP-PKA pathway directly or potentially through a positive feedback 
loop.  A second possibility is that these reagents may not be as membrane 
permeable in stallion sperm in the absence of BSA and/or HCO3
- as they are in 
other species [4,5,14], or perhaps that BSA and/or HCO3
- might be exerting 
effects on tyrosine phosphorylation other than through the generation of cAMP.  
These possibilities are currently under investigation.  In any event, these 
experiments demonstrate that either BSA or HCO3
- needs to be present in order 
for these specific exogenous chemicals to exert their effects (Figure 2.6).  These 
results are different than what has been previously shown in other species and 
further research to investigate possible causes for these findings is underway.  
Using the lectin PNA to assess the percentage of acrosome reacted 
sperm, we were able to correlate our tyrosine phosphorylation results to another 
marker of capacitation.  Indeed, after a 6 h incubation period, both progesterone 
and calcium ionophore were able to induce significantly higher percentages of 
acrosome reacted sperm in our capacitating condition as compared to sperm 
incubated in either non-capacitating medium or exposed to DMSO.    
Furthermore, the rates of acrosomal exocytosis in sperm incubated under 
capacitating conditions and exposed to either progesterone or calcium 
ionophore were higher than previously reported [20,24,48].  Since progesterone 
is considered a more physiological inducer of the acrosome reaction than 
calcium ionophore, these data strongly support the notion that sperm in this 
study had undergone the necessary molecular changes for acrosomal 
exocytosis.   
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Our results are an important step forward in efforts to capacitate stallion 
spermatozoa as evidenced both by the high rates of protein tyrosine 
phosphorylation as well as percentages of acrosome reacted sperm.  
Furthermore, our findings may lead to understanding the molecular mechanisms 
supporting sperm capacitation and the improvement of IVF success rates in the 
horse.   
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CHAPTER 3 
CYCLIC AMP ACTS VIA PROTEIN KINASE A OR GUANINE-NUCLEOTIDE 
EXCHANGE FACTORS TO MODULATE DIFFERENT CAPACITATION-
ASSOCIATED EVENTS IN STALLION SPERM 
 
ABSTRACT 
Capacitation is a complex and poorly understood process that 
encompasses the molecular changes sperm must undergo to successfully 
fertilize an oocyte.  Our laboratory has recently defined in vitro incubation 
conditions that yield time-dependent increases in protein tyrosine 
phosphorylation coupled with significant rates of progesterone-induced 
acrosomal exocytosis in equine sperm. Moreover, these incubation conditions 
support high rates of homologous in vitro fertilization, further demonstrating that 
sperm are capacitated.  Recent experiments in our lab corroborate the notion 
that cAMP production is required for sperm capacitation.  Due to the recent 
discovery of cAMP-dependent guanine nucleotide exchange factors EPAC1 and 
2 in somatic cells and mammalian sperm, the objectives of this study were to 
investigate their role in capacitation-associated events.  Indirect 
immunofluorescence localized EPAC1 to the acrosome and sub-acrosomal ring 
and EPAC2 to the midpiece in equine sperm.  In murine sperm, EPAC1 and 
EPAC2 were also localized to the acrosome and midpiece, respectively.  In 
somatic cells, activation of EPAC has been shown to activate the downstream 
MAPK pathway.  Therefore, the EPAC-specific cAMP analogue 8pCPT was 
added to sperm incubated under both non-capacitating and capacitating 
conditions and the effects on protein tyrosine phosphorylation were evaluated. 
Based on one-dimensional electrophoresis, there were no changes in the 
pattern or levels of protein tyrosine phosphorylation seen at any time point in  
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either species.  Activation of EPAC with 8pCPT did, however, induce acrosomal 
exocytosis in capacitated equine (34%) and murine sperm (37.3%) as compared 
to DMSO-vehicle controls (24.2% and 17%, respectively; P<0.03).  These rates 
were similar to those obtained with progesterone and calcium ionophore-treated 
sperm (P>0.05). Reportedly, EPAC plays a role in the regulation of ion channels 
in somatic cells.  Moreover, capacitation dependent hyperpolarization of the 
sperm plasma membrane has been shown to recruit low voltage activated (LVA) 
T-type Ca
2+ channels, which later open in response to zona pellucida-induced 
membrane depolarization. We hypothesized that EPAC activation may be 
inducing acrosomal exocytosis via depolarization-dependent Ca
2+ influx.  To 
investigate this we first determined the resting membrane potential (Em) of non-
capacitated equine sperm to be -37.11 mV and the Em of capacitated sperm to 
be hyperpolarized to -53.74 mV (P=0.002).  Interestingly, when equine sperm 
were incubated under capacitating conditions in the presence of 8pCPT, Em 
remained in the depolarized state at -32.06 mV, even after 6 hr of incubation.  
This result was similar to sperm in the non-capacitated state (P>0.05) but 
different (P<0.001) from capacitated sperm incubated in the absence of the 
EPAC activator. Taken together, these experiments demonstrate the presence 
of EPAC1 and 2 in equine and murine sperm, support the hypothesis that EPAC 
activation regulates acrosomal exocytosis via its modulation of membrane 
potential and demonstrate a novel role for EPAC in the regulation of sperm 
capacitation. 
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INTRODUCTION 
Ejaculated mammalian spermatozoa are not immediately able to fertilize 
an oocyte but acquire this ability during transit within the female reproductive 
tract through a process termed capacitation [1].  In several mammalian species 
this process can be mimicked in the laboratory by incubating sperm in a defined 
medium [2-5].  Although the molecular basis of capacitation is still poorly 
understood, the ability of sperm to fertilize an oocyte has been correlated with 
time-dependent increases in protein tyrosine phosphorylation, the acquisition of 
acrosomal responsiveness and the induction of hyperactivated motility in all 
species studied thus far (for review see [6] and [7]).  Previous attempts to 
capacitate equine sperm in vitro have remained elusive as evidenced by low 
levels of protein tyrosine phosphorylation [8, 9], low rates of acrosomal 
exocytosis [10-13] and low sperm penetration rates when in vitro fertilization 
(IVF) has been attempted [14-20].  Recently, our laboratory has reported 
defined incubation conditions that yield significant time-dependent increases in 
protein tyrosine phosphorylation correlated with significant rates of 
progesterone-induced acrosomal exocytosis in equine sperm [21; Chapter 2]. 
Moreover, by pairing these in vitro capacitation conditions with the induction of 
sperm hyperactivation we have achieved the highest rates of homologous IVF 
ever reported for this species [22; Chapter 4].   
Although the molecular and biochemical changes leading to sperm 
capacitation are still under investigation, reports in species other than the equine 
show that this process is associated with bicarbonate-dependent increases in 
intracellular cAMP levels generated by soluble adenylyl cyclase (SACY; formally 
known as sAC).  Cyclic AMP then activates protein kinase A (PKA), a 
serine/threonine kinase, which is then transduced into downstream events  
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including protein tyrosine phosphorylation [23].  The inhibition of SACY and/or 
PKA abolishes protein tyrosine phosphorylation signaling and ultimately inhibits 
capacitation [24, 25].  Previously, we demonstrated that the addition of the 
cAMP analog dbcAMP and phosphodiesterase inhibitor IBMX to capacitation 
medium increases the rate of protein tyrosine phosphorylation in stallion sperm.  
However, in non-capacitating medium devoid of BSA and/or bicarbonate, these 
cAMP analogues are unable to induce tyrosine phosphorylation of stallion sperm 
proteins [21].  This is in contrast to what has been reported in other species [2, 
24], and raises the question of whether unique molecular pathways are involved 
in supporting capacitation-dependent events in stallion sperm.  
In this regard, a family of cAMP-activated guanine-nucleotide exchange 
factors (EPAC) has been recently discovered [26]; as a result, a comprehensive 
re-evaluation of pathways previously attributed to cAMP-PKA activation is 
warranted.  There are two known isoforms of EPAC (EPAC1 and EPAC2) that in 
somatic cells have been shown to play roles in ion channel function, intracellular 
calcium signaling, ion transport activity and exocytosis [26].  Because calcium is 
required for sperm capacitation, of special interest is the fact that EPAC1/2 can 
mediate calcium mobilization in three hypothesized ways: 1) by interacting 
directly with inositol 1,4,5-trisphosphate receptors (IP3R) to release calcium from 
intracellular stores; 2) by acting through Rap GTPases to activate protein 
kinases that phosphorylate and regulate the function of calcium release; and/or 
3) by stimulating Rap GTPases that activate phospholipase C (PLC), thus 
generating IP3 [26].  Interestingly, EPAC1 has recently been identified in mature 
human and epididymal mouse sperm [27, 28] and EPAC2 has been identified in 
mouse spermatogenic cells [29].  Given the importance of the aforementioned 
signal transduction pathways in sperm capacitation, it is important to revisit the  
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regulation of these pathways, which were previously attributed to PKA-mediated 
events.  Therefore, in this study, we investigated the roles of SACY, PKA and 
EPAC in capacitation-associated events in stallion sperm.  
 
MATERIALS AND METHODS 
Chemicals and Reagents.  Four-Bromo-Calcium Ionophore A23187 was 
obtained from Calbiochem (San Diego, CA).  Tween 20 was purchased from 
BioRad (Hercules, CA).  Anti-phosphotyrosine monoclonal antibody (mAB), 
4G10, was purchased from Upstate Biotechnology (Lake Placid, NY).  PNA-
Alexa 488, valinomycin and 3,3‟dipropylthiadicarbocyanine iodide (DiSC3(5)) 
were purchased from Invitrogen Corp. (Carlsbad, CA).  8-(p-chlorophenylthio)-
2‟-O-methyladenosine-3‟,5‟-cyclic monophosphate (8pCPT) was purchased from 
BioLog Life Science Institute (SanDiego, CA).  Sp-5,6-DCl-cBIMPS and 
myristolated protein kinase A inhibitor (PKI) were purchased from EMD 
Biosciences, Inc. (Gibbstown, NJ).  The acquisition of the SACY inhibitor KH7 
was facilitated by Drs. Levin and Buck (Department of Pharmacology, Weill 
Cornell Medical College, New York, NY [25]) and purchased from the Abby and 
Howard P. Milistein Synthetic Chemistry Core Facility also at Weill Cornell 
Medical College.  EPAC1 (C-17) and EPAC2 (H220) antibodies, and EPAC1 
peptide (C-17P) were purchased from Santa Cruz Biotechnology, Inc (Santa 
Cruz, CA).  Carbonyl cyanide m-chlorophenylhydrazone (cccp) and all other 
chemicals were purchased from Sigma Chemical Company (St. Louis, MO), 
unless otherwise stated. 
Sperm Culture Media.  Sperm were incubated as previously described 
[21] in modified Whittens (MW; 100 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 5.5  
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mM glucose (anhydrous), 22 mM HEPES, 4.8 mM lactic acid hemicalcium salt 
and 1.0 mM pyruvic acid) [30].  Negative control, non-capacitating medium was 
always devoid of BSA and NaHCO3 and also served as transport medium.  
Capacitating conditions for stallion sperm were achieved by adding 25 mM 
NaHCO3 and 7 mg/ml BSA to the non-capacitating base medium and the final 
pH was adjusted to 7.25 with HCl for both conditions.  Capacitating conditions 
for mouse sperm were achieved by adding 15 mM NaHCO3 and 3 mg/ml BSA to 
the non-capacitating base medium and the final pH was adjusted to 7.35 with 
HCl for both conditions. 
Semen Collection and Preparation.  Semen was collected with an 
artificial vagina from seven adult stallions of proven fertility in compliance with 
IACUC guidelines.  After visual evaluation of sperm motility under light 
microscopy on a heated stage and assessment of sperm concentration using a 
534B MOD1 Densimeter (Animal Reproduction Systems, Chino, CA), the sperm 
rich fraction was diluted 2:1 (vol:vol) in pre-warmed non-capacitating MW and 
transported to the laboratory at 37°C for immediate processing.  Samples were 
centrifuged in 15-ml conical tubes at 100 x g for 1 min at 37°C to remove 
particulate matter and dead sperm.  The supernatant was then transferred to a 
14-ml round- bottom centrifuge tube and centrifuged at 600 x g for 5 min (37°C), 
and resuspended in non-capacitating or capacitating MW to a final concentration 
of 10 x 10
6 sperm/ml.  Samples were incubated in 500 μl aliquots in polyvinyl 
alcohol coated 5-ml round-bottom tubes [31] at 37
oC in a humidified air 
atmosphere.   
Mouse epididymal sperm were isolated using a swim-out method.  Briefly, 
epididymides were placed into 500 μl of pre-warmed non-capacitating MW in a 
1.5-ml round bottom tube and allowed to swim out for 10 min in a 37°C water  
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bath.  An additional 1 ml of medium was added before centrifugation at 150 x g 
at room temperature.  The top 1 ml of supernatant was removed and sperm 
were resuspended at 6.6 x10
6 sperm/ml.  Samples were incubated in non-
capacitating and capacitating MW in 300 μl aliquots in polyvinyl alcohol coated 
5-ml round bottom tubes at 37
oC.  
SDS-PAGE and Immunoblotting.  Stallion or mouse sperm were 
incubated under non-capacitating and capacitating conditions for 0, 2, 4 and 6 h 
or 0, 30 and 60 min, respectively, in the presence and absence of various 
pharmacological reagents.  Following incubation, samples were processed for 
SDS-PAGE and immunoblotting as previously described [21].  Briefly, samples 
were washed by centrifugation and the final pellet was resuspended in sample 
buffer [32] containing 40 mM DTT.  Samples were then boiled for 5 minutes.  
The total volume of extract corresponding to equal numbers of sperm in each 
sample (5 x 10
6 stallion or 2 x 10
6 mouse sperm) was loaded on 10% SDS gels.  
Separated proteins were blotted onto Immobilon P membranes (Millipore, Inc., 
Billerica, MA), and blocked for 1 h with 1:10 (vol:vol) dilution of cold water fish 
skin gelatin in TBS-Tween 20.  TBS-Tween 20 was used for all subsequent 
antibody incubations and washes.  Immunodetection of tyrosine phosphorylated 
proteins was performed using a monoclonal antibody against phosphotyrosine 
at a 1:10,000 dilution for 1 h, and incubated for 30 min with goat anti-mouse 
horseradish peroxidase-coupled IgG.  Immunodetection of EPAC proteins was 
performed using polyclonal antibodies against EPAC1 or EPAC2 at a 1:200 
dilution for 3 h, and incubated for 2 h with either donkey-anti-goat (EPAC1) or 
goat-anti-rabbit (EPAC2) horseradish peroxidase-coupled IgG.  
Immunoreactivity was visualized using enhanced chemiluminescence detection 
with an ECL kit (Amhersham Corp., Piscataway, NJ) according to the  
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manufacturer‟s directions.  Immunoblots shown are representative of three 
replicates with three different stallions and/or mice.   
Immunofluorescence. Sperm suspensions  (0.5 x 10
6) were washed with 
PBS by centrifugation (2000 x g for 2 min), resuspended in 125 μl of PBS and 
allowed to settle on glass slides for 5 min at room temperature.  Excess fluid 
was then aspirated off, and slides were allowed to air dry.  Slides were fixed in 
2% paraformaldehyde for ≥10 min, permeabilized with 0.1% Triton X-100 in PBS 
and blocked with 5% BSA in PBS for 2 h at room temperature.  Primary 
antibodies for EPAC1 or EPAC2 (1:100 in blocking solution) were added and 
slides were incubated at 4 C overnight in a humidified chamber.  Controls for 
EPAC1 were incubated in blocking peptide (1:100 in blocking solution) and 
controls for EPAC2 were incubated in pre-immune rabbit IgG (5 mg/ml in normal 
saline) at 4 C overnight in a humidified chamber.  Slides were washed with PBS 
and incubated with either donkey-anti-goat FITC conjugated IgG (EPAC1) or 
goat-anti-rabbit FITC conjugated IgG (EPAC2) secondary antibodies (1:200 in 
blocking solution) for ≥2 h at room temp in the dark.  Slides were washed again 
with PBS and mounted with Vectashield (Vector Laboratories, Burlingame, CA).  
Slides were evaluated using a fluorescent Zeiss Imager ZI microscope 
(Thornwood, NY) with Green Fluorescent Protein (GFP) filters the following day. 
Acrosome Reaction Assay.  Stallion sperm were resuspended in 
capacitating media for 0 or 6 h.   Induction of acrosomal exocytosis was 
performed by incubating sperm for an additional 30 min in the presence of 1 mM 
8pCPT, 3 μM progesterone, 5 μM calcium ionophore A23187 [21] or an equal 
volume of vehicle control (DMSO; 0.5% vol:vol).  Sperm were washed with PBS 
by centrifugation and resuspended in 125 μl of PBS.  Acrosomal status of sperm 
was evaluated with PNA-Alexa 488 (final concentration 0.024 mg/ml) as  
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previously described [21].  Briefly, sperm were incubated for 10 min in the 
presence of PNA-Alexa 488, washed, fixed with 2% paraformaldehyde for 10 
min, washed again and mounted with Vectashield.  Slides were scored (630x) 
for acrosomal status using an upright fluorescent Zeiss Imager ZI microscope 
(Thornwood, NY) with Green Fluorescent Protein (GFP) filters.  Two hundred 
morphologically normal sperm were counted per slide and evaluation was 
performed blindly of treatment status.  Sperm were categorized as acrosome 
intact, intermediate or acrosome reacted as previously described. 
Mouse sperm were incubated in capacitating medium for 0 or 1 h.  
Induction of acrosomal exocytosis was performed by incubating sperm for an 
additional 10 min in the presence of 1 mM 8pCPT, 20 μM progesterone [33] or 
an equal volume of vehicle control (DMSO; 0.5% vol:vol).  Sperm were washed 
with PBS by centrifugation and fixed with 1% paraformaldehyde (400 μl total 
volume) for 10 min.  Sperm were pelleted by centrifugation to remove fixative 
and washed twice with 500 μl of 100 mM sodium acetate.  After the second 
wash, the supernantant was removed down to ~ 35 μl, then sperm were 
smeared onto slides and allowed to air dry.  Slides were stained with 0.22% 
Coomassie blue G250 (wt:vol) in 50% methanol and 10% in acetic acid in a 
Coplin jar for 10 min.  Slides were rinsed with PBS, air dried and mounted with 
Mount-Quick (Diado Sangyo Co., Ltd., Japan).  Acrosomal status was 
immediately evaluated using an Olympus BH2 microscope (100X; Center 
Valley, PA); staining over the acrosome indicated acrosome intact sperm [34].  
Two hundred morphologically normal sperm were counted per slide and 
evaluation was performed blindly of treatment status. 
Membrane Potential Assay in Stallion Sperm Populations.  Membrane 
potential (Em) was measured using freshly ejaculated stallion semen or semen  
  61 
that was diluted in INRA 96 Extender (Breeder‟s Choice, LLC, Aubrey, TX) and 
cooled to 4 C for shipping in an Equitainer (Hamilton Research, Inc., South 
Hamilton, MA) following standard recommendations for commercial cooled-
shipment.  Fresh semen was washed and processed as described above; 
cooled semen was washed from extender by dilution in room temperature PBS 
and centrifugation.  Sperm were then resuspended at 10 x 10
6 sperm/ml (500  l 
total volume) in non-capacitating, capacitating, or capacitating medium plus 1 
mM 8pCPT and incubated in a 37 C water bath.  Membrane potential 
measurements for non-capacitated sperm were taken at time points throughout 
the experiment, whereas sperm incubated under capacitating conditions with 
and without 1 mM 8pCPT were evaluated between 3-6 h of incubation.   
Membrane potential was measured as previously described [35].  Prior to 
Em measurements, sperm were diluted in 1.5 ml total volume of either non-
capacitating or capacitating medium.  The fluorescent probe DiSC3(5) (1  M 
final concentration) was added to the sperm suspension followed by the addition 
of 1  M cccp (final concentration) was also added, to collapse mitochondrial 
membrane potential.  After a 10-min incubation with these reagents (37 C), 
sperm were transferred to a gently stirred cuvette (37 C) and the fluorescence 
was continuously recorded at 620/670 nm (excitation/emission).  Calibration was 
performed as described by Demarco et al. [35] with the addition of 1  M 
valinomycin and sequential additions of KCl; membrane potential was then 
calculated using the Nernst equation and expressed as mV, as previously 
described [36].   
Statistical Analysis.    Raw data for percent acrosome reacted sperm 
were transformed using arcsin square root and then analyzed by two-way 
repeated measures ANOVA using SigmaStat software (San Jose, CA).  Raw  
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data for membrane potential was analyzed using a one-way ANOVA; when 
significant differences were detected (P<0.05) the Student-Newman-Keuls 
method was applied to assess all pairwise multiple comparisons.  
 
RESULTS 
SACY-Generated cAMP Supports Capacitation-Induced Increases in Protein 
Tyrosine Phosphorylation.  Based on studies performed in mammalian 
spermatozoa, it is accepted that the activation of SACY by bicarbonate and the 
subsequent generation of cAMP plays a crucial role in the downstream 
accumulation of tyrosine-phosphorylated proteins [6].  In this regard, the SACY-
specific inhibitor KH7 can abrogate the time-dependent increases in protein 
tyrosine phosphorylation in mouse sperm incubated in capacitating conditions 
[25].  Because capacitation-dependent protein tyrosine phosphorylation in 
stallion sperm requires the presence of bicarbonate in the incubation medium 
[21], we hypothesized that KH7 would inhibit tyrosine phosphorylation in this 
species as well.  We performed parallel experiments in mouse sperm as an 
internal laboratory control. Notably, twice the concentration of KH7 was required 
in stallion sperm (60  M; Figure 3.1A) to achieve the same level of inhibition 
obtained in mouse sperm (30  M; Figure 3.1B; [25]).  Lower concentrations of 
KH7 (15 and 30  M) were not sufficient to inhibit tyrosine phosphorylation in 
stallion sperm (data not shown).  This may suggest a more robust control of 
these pathways in equine sperm or perhaps inherent differences related to the 
origin of the sperm samples; that is, ejaculated (equine) vs. epididymal, thus 
possibly affecting membrane permeability to KH7.   
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Although this experiment supports previous studies demonstrating that 
SACY activation is responsible for protein tyrosine phosphorylation in stallion 
sperm, we had previously reported that the combination of dbcAMP and IBMX 
was unable to support time-dependent increases in protein tyrosine 
phosphorylation in stallion sperm incubated under non-capacitating conditions 
[21].  Therefore, we tested the more membrane permeable and 
Figure 3.1 Representative immunoblot for protein tyrosine phosphorylation of 
stallion (A) and mouse sperm (B) incubated in  non-capacitating (NC), 
capacitating (C) or capacitating conditions plus KH7 (60 μM in stallion sperm; 
30 μM in mouse sperm).  
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phosphodiesterase-resistant cAMP analog cBIMPS.  Sperm incubated in 
capacitating MW plus 1 mM cBIMPS demonstrated increases in protein tyrosine 
phosphorylation higher than those observed in sperm incubated under 
capacitating conditions alone (Figure 3.2A, lane 4).  Altogether, we concluded 
that SACY-dependent cAMP production is required for the downstream 
capacitation-dependent protein tyrosine phosphorylation cascade in stallion 
sperm. 
Inhibition of PKA Blocks the Capacitation-Dependent Increase in Protein 
Tyrosine Phosphorylation.  Sperm capacitation research in several mammalian 
species points at PKA as being the immediate effector of SACY-generated 
cAMP leading to downstream protein tyrosine phosphorylation events [2, 6, 24].  
To investigate this, we incubated stallion sperm under capacitating conditions in 
the presence of the PKA-specific inhibitor PKI [37].  As shown in Figure 3.2A 
(lane 3), 60  M PKI was sufficient at inhibiting the capacitation-dependent 
increases in tyrosine phosphorylation; lower concentrations of PKI (10, 20, and 
30  M) did not have the same inhibitory effect (data not shown).  As a control for 
this pharmacological experiment, mouse sperm were also incubated under 
capacitating conditions in the presence of PKI.  Figure 3.2B shows that as low 
as 20  M PKI completely inhibited capacitation-dependent tyrosine 
phosphorylation in mouse sperm. 
These experiments supported the hypothesis that PKA promotes 
downstream protein tyrosine phosphorylation in stallion sperm, however, we 
wanted to test the possibility that other cAMP targets contribute to these effects.  
For this purpose, sperm were incubated in capacitating MW, with or without the 
PKA inhibitor PKI (60  M final concentration) and 1 mM cBIMPS.  Interestingly,  
  
  65 
A            B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Representative immunoblots for protein tyrosine phosphorylation in 
(A) stallion and (B) mouse sperm.  Sperm were incubated under capacitating  
(Cap) and non-capacitating (NC) conditions in the presence of the cAMP 
analog cBIMPS (1mM) and/or increasing concentrations of the PKA inhibitor 
PKI. 
 
in the presence of PKI, sperm incubated with the addition of cBIMPS still 
underwent tyrosine phosphorylation to levels markedly higher than those seen in 
the non-capacitating condition or capacitating condition with the addition of PKI 
alone (Figure 3.2A, lanes 5, 6).  That is, the addition of PKI was not sufficient at 
completely inhibiting the effects of cBIMPS, which suggests that there are cAMP 
targets other than PKA that stimulate tyrosine phosphorylation in stallion sperm. 
EPAC1 and EPAC2 are Present in Stallion and Mouse Sperm.  The 
cAMP-dependent guanine nucleotide exchange factors EPAC1 and EPAC2 
have been recently identified in somatic cells [26] and mammalian sperm [27, 
38].  EPAC1/2 has been shown to play a role in activating the MAPK pathway in  
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somatic cells [39, 40]; paired with the results reported above (Figure 3.2), we 
hypothesized that their activation contributes to PKA-independent increases in 
protein tyrosine phosphorylation. 
  We first investigated the expression of these proteins in stallion sperm. 
Immunoblotting of sperm extracts was performed using polyclonal antibodies 
against EPAC1 or EPAC2.  A band at ~ 32 kD (Figure 3.3) and at ~ 45 kD 
(Figure 3.3), corresponding to EPAC1 and EPAC2 proteins, respectively, was 
observed.  These bands did not appear when the primary antibodies were 
omitted (Figure 3.3).  Additionally, while the full length EPAC proteins are 120 – 
126 kD, the size of the observed protein bands correspond to the predicted 
sizes of the N-term regulatory subunits for EPAC1 and EPAC2, as determined 
by BLAST and BLAT searches of the mouse and horse genomes, respectively 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 Representative immunoblot of EPAC1 
and EPAC2 in stallion (lanes 1 and 3) and mouse 
(lanes 2 and 4) sperm.   
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[26] (NCBI accession numbers NP_659099 and CAM24393; 
University of California, Santa Cruz horse genome browser 
[www.genome.ucsc.edu]).  Therefore, these protein bands are most likely 
degradation products of the full-length EPAC proteins.  As detected via indirect 
immuofluorescence, EPAC1 localized to the acrosome and sub-acrosomal ring 
of stallion sperm (Figure 3.4A); in agreement with previous reports, EPAC1 
localized to the acrosome of mouse sperm (Figure 3.4E) [27].  EPAC 2 localized 
to the midpiece of both stallion (Figure 3.5A) and mouse sperm (Figure 3.5 E). 
  Because there are no membrane permeable antagonists for EPAC 
available [41], we used the EPAC-specific cAMP analogue 8pCPT [26] to 
investigate the potential involvement of these proteins in capacitation-dependent 
protein tyrosine phosphorylation events.  For this purpose, stallion and mouse 
sperm were incubated under non-capacitating and capacitating conditions with 
and without 1 mM 8pCPT for 0, 2, and 4 h (stallion sperm) or 0, 30 and 60 min 
(mouse sperm).  As shown in Figure 3.6, there was no discernable effect of 
8pCPT on tyrosine phosphorylation in either incubation condition or species. 
These results support a primary role for a cAMP-PKA pathway in driving these 
events, as reported in other species. 
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Figure 3.4 Immunofluorescence localization of EPAC1 in stallion and 
mouse sperm.  (A) EPAC1 localizes to the acrosome and sub-acrosomal 
ring in stallion sperm; (B) corresponding bright field image for A; (C) 
peptide control demonstrating background levels of fluorescence with 
corresponding bright field image (D); (E) EPAC1 localizes to the 
acrosome in mouse sperm; (B) corresponding bright field image for E; 
(G) pre-immune rabbit IgG control demonstrating background levels of 
fluorescence with corresponding bright field image (H).  
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The EPAC-specific cAMP Analogue 8pCPT Induces Acrosomal 
Exocytosis in Capacitated Stallion and Mouse Sperm.  Because EPAC1 
localized to the acrosome, we next hypothesized that EPAC activation might 
play a role in the induction of acrosomal exocytosis in stallion and/or mouse 
sperm.  In support of this, Branham et al. have shown that activation of EPAC 
via 8pCPT in permeabilized human spermatozoa contributes to the calcium-
dependent phase of the acrosome reaction [28].   
In stallion sperm incubated under capacitating conditions (6 h), activation 
of EPAC with 8pCPT induced 34.3% acrosomal exocytosis rates, which was 
Figure 3.5 Immunofluorescence localization of EPAC2 in stallion and mouse 
sperm.  EPAC2 localizes to the midpiece in stallion (A) and mouse (E) sperm; 
(B and F) corresponding bright field images for A and E, respectively; (C and 
G) secondary antibody alone controls demonstrating background levels of 
fluorescence with corresponding bright field images (D and H).   
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higher (P=0.03) than DMSO-vehicle controls (24.2%; Figure 3.7A).  Moreover, 
this percentage was similar (P>0.05) to rates achieved with both progesterone 
and calcium ionophore (47.9% and 44.5%, respectively).  Conversely, 8pCPT 
did not induce exocytosis in non-capacitated (0 h) stallion sperm (data not 
shown; P>0.05 for all conditions).  Similarly, in mouse sperm, 8pCPT induced 
45% exocytosis rates (Figure 3.7B), which was higher (P=0.004) than DMSO 
controls (27.5%) but comparable (P>0.05) to progesterone (47.9% acrosomal 
exocytosis).  From these studies, we concluded that activation of EPAC via 
8pCPT induces acrosomal exocytosis in capacitated stallion and mouse sperm.   
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Representative immunoblots of protein tyrosine phosphorylation in 
stallion (A) and mouse sperm (B) incubated under non-capacitating (NC) and 
capacitating (C) conditions in the presence (+) and absence (-) of 8pCPT.  
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Figure 3.7 Percentages of acrosomal exocytosis in stallion (A) and 
mouse sperm (B) incubated under capacitating conditions and 
exposed to DMSO (solvent control), calcium ionophore A23187 (CaI), 
progesterone (P4), or the EPAC-specific cAMP analogue 8pCPT. 
(Mean   SEM). 
a 
b  b 
b 
a 
b  b  
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8pCPT Maintains Sperm Plasma Membrane in the Depolarized State. 
Hyperpolarization of the sperm plasma membrane, which has been 
demonstrated to occur during capacitation, is required for fertility [36, 42, 43].  In 
the mouse, this represents a change in membrane potential (Em) from ~ -30 mV 
to ~ -60 mV, is dependent on the activation of various ion channels and 
prepares the sperm for acrosomal exocytosis [36, 42, 44].  Currently, cAMP is 
believed to play a role in hyperpolarization of the sperm plasma membrane 
through a PKA-mediated pathway [42]; however, in various somatic cell lines, 
activation of EPAC via 8pCPT has been shown to have effects on ion channels 
known to play a role in the modulation of Em [40, 45, 46].  The potential role of 
EPAC in this event has yet to be investigated in mammalian sperm.  For this 
purpose, stallion sperm were incubated in non-capacitating, capacitating, and 
capacitating medium with the addition of 1 mM 8pCPT for up to 6 h.  Membrane 
potential of non-capacitated sperm was measured throughout the experiment; 
Em for sperm incubated under capacitating conditions with and without 8pCPT 
was measured between 3-6 h of incubation.  Non-capacitated stallion sperm 
displayed a resting mean Em of -37.11 mV versus capacitated sperm, which 
hyperpolarized to -53.74 mV; this capacitation-dependent hyperpolarization was 
significant (P=0.002).  Interestingly, when sperm were incubated under 
capacitating conditions in the presence of 8pCPT, sperm Em was maintained in 
the depolarized state at -32.06 mV; this result was comparable to non-
capacitated sperm (P>0.05) but different from capacitated sperm (P<0.001; 
Figure 3.8).  This experiment not only determines the resting and capacitation-
associated membrane potentials for stallion sperm, it also demonstrates that 
EPAC activation results in membrane depolarization. 
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DISCUSSION 
Our previous work suggested inherent differences in the physiological 
response of stallion sperm to pharmacological agents used to ascertain the 
pathways linked to sperm capacitation [21].  Moreover, the recent discovery of 
cAMP-dependent guanine nucleotide exchange factors EPAC1 and EPAC2 in 
somatic and germ cells prompted the re-evaluation of pathways previously 
attributed to cAMP-PKA activation. Therefore, in this study, we sought to 
separate the roles of PKA and EPAC activation in capacitation-associated 
events in stallion sperm.  
While it is widely reported that capacitation-dependent protein tyrosine 
phosphorylation follows a cAMP-PKA driven pathway, we had previously shown 
that dbcAMP-IBMX were unable to enhance tyrosine phosphorylation in stallion 
sperm incubated in non-capacitating conditions [21], as shown in all other 
Figure 3.8 Average membrane potential (Em) of non-capacitated stallion 
sperm (NC), capacitated stallion sperm (Cap) and stallion incubated under 
capacitating conditions in the presence of 8pCPT (8P). (Mean   SEM). 
 
a 
b 
a  
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species studied.  In the present study, we report that PKI can inhibit, albeit not 
completely (band at ~ 75 kD), time-dependent increases in protein tyrosine 
phosphorylation in stallion sperm incubated under capacitating conditions 
(Figure 3.2, lane 3).  Moreover, PKI did not completely inhibit the effects of 
cBIMPS in our protein tyrosine phosphorylation studies (Figure 3.2, lanes 5,6).    
Altogether, these results made us reconsider the analysis of these pathways in 
stallion sperm.  
Additionally, in somatic cells and in mouse sperm, activation of EPAC 
with 8pCPT results in the direct activation of Rap 1 [27, 47], and in some cell 
types, this is followed by ERK1/2 activation [39].  Therefore, we hypothesized 
that EPAC might be playing a role in capacitation-associated protein tyrosine 
phosphorylation in stallion sperm.  In one-dimensional gel electrophoresis, 
however, we were unable to detect any changes in phosphotyrosine with the 
addition of 8pCPT in either horse or mouse sperm.  Under capacitating 
conditions, marked levels of tyrosine phosphorylation are normally seen; 
therefore it is possible that an effect of 8pCPT could be masked.  Under non-
capacitating conditions, the absence of BSA and bicarbonate may preclude 
appropriate membrane permeability of the cAMP analogue (particularly in 
stallion sperm which are ejaculated and therefore exposed to coating by 
components of seminal plasma).  Alternatively, 8pCPT may have been rapidly 
hydrolyzed to an inactive form by phosphodiesterases (PDEs).  To be certain 
that our negative results were not due to membrane permeability issues or PDE 
hydrolyzation, we incubated stallion sperm under non-capacitating conditions 
plus 8pCPT in the presence of BSA, IBMX or both.  In these studies, we 
observed no effect on tyrosine phosphorylation and levels of tyrosine 
phosphorylation remained at non-capacitated control levels (data not shown).   
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Our results, therefore, support only cAMP-PKA driven induction of protein 
tyrosine phosphorylation during stallion sperm capacitation. 
Most notably, however, activation of EPAC with 8pCPT induced rates of 
acrosomal exocytosis in capacitated stallion (34%) and mouse sperm (45%) 
comparable to those obtained with progesterone and/or calcium ionophore-
treated sperm (P>0.05).  We hypothesized a potential link between EPAC 
activation, changes in membrane potential and acrosomal exocytosis.  In 
support of this, we demonstrated that incubation of stallion sperm under 
capacitating conditions in the presence of the EPAC-selective agonist 8pCPT 
maintained sperm Em in the depolarized state, thus precluding membrane 
hyperpolarization as observed under the capacitating conditions.  
Indeed, capacitation-dependent hyperpolarization of the sperm plasma 
membrane is required for fertility [36].  In the mouse, this represents a change in 
membrane potential from ~ -30 mV to ~ -60 mV [36].  We report herein the 
resting membrane potential of stallion sperm to be -37.11 mV, and show that 
capacitated stallion sperm hyperpolarize to -53.74 mV (P=0.002). Currently, 
cAMP is believed to play a role in hyperpolarization of the sperm plasma 
membrane through a PKA-mediated pathway [42].  The current model of 
capacitation-induced plasma membrane hyperpolarization involves increases in 
intracellular cAMP, the activation of PKA, followed by phosphorylation of the 
cystic fibrosis transmembrane conductor (CFTR).  Activation of CFTR allows the 
influx of negatively charged Cl
- ions as well as the inhibition of the constitutively 
active epithelial sodium channels (ENaC), thus preventing the influx of Na
+ [36, 
42].  Moreover, capacitation-associated increases in intracellular pH activate 
K
+
ATP channels, also contributing to membrane hyperpolarization [48].   
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It has been shown that the activation of EPAC with 8pCPT will induces 
hyperpolarization in cerebellar neurons [40].  Conversely, in various other 
excitable and non-excitable somatic cells, EPAC activation has been observed 
to have effects on the above mentioned ion channels such that a depolarization 
of the plasma membrane would be expected.  For instance, in pancreatic beta 
cells, Kang et al. observed an EPAC-mediated inhibition of K
+
ATP channels [46]; 
in rat pulmonary epithelial cells 8pCPT increased the channel open probability of 
ENaC [45]; and, in rat hepatocytes, 8pCPT stimulated an outwardly rectifying Cl
- 
current [49].  
Additionally, the observations in the present study that: 1) EPAC1 
localized to the acrosomal region of stallion and mouse sperm; 2) 8pCPT 
induced acrosomal exocytosis similarly in both species; and, 3) 8pPCT 
maintained stallion sperm in the depolarized state, are all in accordance with 
work demonstrating ZP3-induced exocytosis as a result of plasma membrane 
depolarization [43, 44].  In this model, capacitation-dependent hyperpolarization 
results in the recruitment of low voltage-activated (LVA) T-type ion channels, 
which are then available for activation. Contact with ZP3 stimulates membrane 
depolarization and opening of LVA channels, thus resulting in calcium influx and 
the initiation of acrosomal exocytosis [43].  Since 8pCPT interfered with 
fluorescent recordings during membrane potential determination, we were 
unable to ascertain its immediate effect when added to capacitated stallion 
sperm.  However, because 8pCPT did maintain sperm in the depolarized state, 
we propose a model (Figure 3.9) in which ZP-directed EPAC activation may be 
involved in inducing acrosomal exocytosis by triggering membrane 
depolarization, through yet to be determined ion channel(s).  We hypothesize 
that this, in turn, results in the activation of LVA channels previously recruited as   
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Figure 3.9 In the non-capacitated state, the cystic fibrosis transmembrane 
regulator (CFTR) is in the closed state, while the epithelial sodium ion channel 
(ENaC) is constitutively open allowing for the influx of Na
+ ions.  Additionally, 
the potassium ATP ion channel (K
+
ATP) is inwardly rectifying.  Collectively, this 
results in a depolarized resting membrane potential of ~ -37 mV.  At this 
membrane potential, the low voltage activated T-Type calcium channels (LVA) 
are not able to open.  During capacitation, cAMP-dependent PKA 
phosphorylates CFTR, thus opening this channel allowing for the influx of Cl
- 
ions; additionally, activation of CFTR inhibits ENaC channels.  The increase of 
intracellular pH that also accompanies capacitation switches the K
+
ATP channel 
from an inwardly rectifying channel to an outwardly rectifying channel.  As a 
result, capacitated sperm have a hyperpolarized membrane potential of ~ -54 
mV.  This hyperpolarization allows for the recruitment of LVA channels, which 
can now be opened upon proper stimulation. We hypothesize that when a 
capacitated sperm contacts the zona pellucida of an oocyte, cAMP-dependent 
EPAC is activated, which in turn inhibits CFTR, allowing ENaC channels to 
become constitutively active again.  Evidence also suggests that activation of 
EPAC inhibits K
+
ATP channels.  Collectively, this results in a rapid 
depolarization of the plasma membrane (~ -32 mV), the opening of LVA 
channels, and the resulting Ca
2+ influx triggers acrosomal exocytosis.  
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a result of capacitation-dependent hyperpolarization, a sudden calcium influx, 
and acrosomal exocytosis.  Future studies should aim at identifying the 
particular ion channels through which EPAC may facilitate sperm membrane 
depolarization.  
Taken together, these experiments demonstrate a novel role for EPAC in 
stallion sperm capacitation, as it pertains to acrosomal exocytosis and plasma 
membrane potential.  Moreover, this study highlights the importance of 
investigating EPAC in a comparative manner with PKA, as both are cAMP-
dependent proteins potentially playing diverging roles in sperm physiology. 
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CHAPTER 4 
HYPERACTIVATION OF STALLION SPERM IS REQUIRED FOR 
SUCCESSFUL IN VITRO FERTILIZATION OF EQUINE OOCYTES
2 
 
ABSTRACT  
Capacitation is a complex and not well-understood process that 
encompasses all the molecular changes sperm must undergo to successfully 
fertilize an oocyte. In vitro fertilization has remained elusive in the horse as 
evidenced by low in vitro fertilization (IVF) rates (0-33%); moreover, only two 
foals have ever been produced using IVF. Incubation of stallion sperm in 
modified Whittens supplemented with BSA and sodium bicarbonate yielded 
significant rates of time-dependent protein tyrosine phosphorylation and 
induced acrosomal exocytosis, consistent with capacitation. The objective of 
this study was to characterize stallion sperm hyperactivation and to test 
whether hyperactivation of capacitated sperm supported equine IVF. 
Treatment of sperm with procaine, an anesthetic shown to induce 
hyperactivation in other mammalian species, resulted in the decrease of three 
motility variables indicative of hyperactivation: Straight line velocity (VSL; P = 
0.029), straightness (STR; P = 0.001), and linearity (LIN; P = 0.002). We 
demonstrated that procaine-induced hyperactivation was not regulated by 
changes in protein tyrosine phosphorylation, and that it did not induce 
acrosomal exocytosis in capacitated sperm as compared to calcium ionophore 
(P > 0.05), similar to findings in the bovine. Most notably, by coupling our 
capacitating conditions with the induction of hyperactivation using procaine, 
                                                        
2 McPartlin, LA, Suarez, SS, Czaya, CA, Hinrichs, K, Bedford-Guaus, SJ. Biol 
Reprod. 2009 February 4;81(1):199-206. Reprint with permission from the 
Society for the Study of Reproduction.  
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we have achieved the novel result of substantial and reproducible percentages 
of fertilized mare oocytes (60.7%) in our IVF experiments. Conversely, sperm 
incubated in capacitating conditions but not treated with procaine did not 
fertilize (0%). These results support the hypothesis that capacitation and 
hyperactivation are required for successful IVF in the equine. 
 
INTRODUCTION 
Only two foals have ever been produced using in vitro fertilization (IVF) 
technology [1] despite decades of work addressing this topic. Reported 
fertilization rates have ranged from 0% to 33% [2-8] and these results were 
inconsistent even between studies performed by the same laboratories [4-6]. 
Since equine IVF is equally unsuccessful with in vivo-matured and in vitro-
matured oocytes [1], and oviductal transfer of in vitro-matured equine oocytes to 
inseminated mares results in fertilization rates comparable to those obtained by 
natural mating [8], it is likely that the low sperm penetration rates observed in 
IVF studies have stemmed from the inability to appropriately capacitate and/or 
hyperactivate stallion sperm in the laboratory. 
Capacitation comprises the changes that ejaculated sperm must undergo 
to become fertilization-competent [9]. Although the molecular basis of 
capacitation is still poorly understood, the ability of sperm to fertilize an oocyte 
has been correlated with time-dependent increases in protein tyrosine 
phosphorylation and the acquisition of acrosomal responsiveness in all species 
studied thus far (for review see [10]). Previous attempts to capacitate sperm in 
vitro have remained elusive in the horse as evidenced by low levels of protein 
tyrosine phosphorylation [11, 12], low rates of acrosomal exocytosis [13-16] and 
low sperm penetration rates when IVF has been attempted [2-8]. Recently, our  
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laboratory has reported defined incubation conditions that yield significant time-
dependent increases in protein tyrosine phosphorylation correlated with 
significant rates of progesterone induced acrosomal exocytosis, suggesting that 
sperm are undergoing changes consistent with capacitation [17].  
In addition, penetration of the outer vestments of the oocyte at fertilization 
requires a change in the pattern of sperm motility that has been termed 
hyperactivation [18-20]. The acquisition of hyperactivated sperm motility has 
been observed within the oviducts of mammals at the time of fertilization [21-23] 
and is required for zona pellucida penetration [19, 24]. It is also believed to play 
a role in the ability of sperm to detach from the oviductal wall [21], navigate the 
labyrinthine environment of the oviduct [25], and penetrate the viscous mucoid 
environment encountered in the female reproductive tract [22, 26; for review see 
27]. The precise motility pattern that defines hyperactivation is species-specific; 
however, it is generally characterized by increases in lateral head displacement, 
flagellar bend amplitude and beat asymmetry [20, 24, 28].  
Capacitation and hyperactivation are often linked together in the 
continuum of changes that a sperm must undergo to fertilize an oocyte; 
moreover, both processes require calcium, bicarbonate and the activation of 
cAMP synthesis [29-32]. However, the pathways that regulate these events are 
considered separable and independent [27, 33, 34]. This has been 
demonstrated in Catsper null mutant mice whereby disruption of any CATSPER 
proteins (which form alkaline activated Ca
2+ channels) resulted in normal sperm 
production, protein tyrosine phosphorylation patterns and rates of acrosomal 
exocytosis; however, the Catsper null sperm failed to hyperactivate, could not 
penetrate zona-intact oocytes and as a consequence these mice were infertile 
[18, 19]. In vitro- incubated bovine sperm that exhibit markers of capacitation do  
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not hyperactivate; however, hyperactivation can be exogenously induced in 
capacitated as well as non-capacitated sperm by exposure to procaine [33], 
further supporting the hypothesis that capacitation and hyperactivation are 
independent processes. Although the exact mechanism by which procaine 
induces hyperactivation is not known, it is believed to stimulate calcium influx by 
increasing the permeability of the plasma membrane to calcium [34]. Although 
Rathi et al. [35] designated certain motility parameters, as measured by 
computer assisted semen analysis (CASA), as indicative of hyperactivated 
motility in equine sperm, none of the treatments tested in that study significantly 
affected the proportions of sperm showing these patterns. Thus, the pattern of 
hyperactivation and its associated measures of motility have not been defined in 
stallion sperm.  
Altogether, the information above suggests that successful IVF in the 
horse might require defined and specific conditions that support sperm 
capacitation in vitro, but also the acquisition of hyperactivated motility. 
Therefore, the first objective of this study was to characterize the pattern of 
motility and motion measures associated with stallion sperm hyperactivation. 
The second objective of this study was to test whether the induction of 
hyperactivation in sperm incubated under capacitating conditions supports 
fertilization of in vitro matured mare oocytes.  
 
MATERIALS AND METHODS 
General Methods 
Chemicals and reagents. Four-Bromo-Calcium Ionophore A23187 was 
obtained from Calbiochem (San Diego, CA). Tween 20 was purchased from 
BioRad (Hercules, CA). Anti-phosphotyrosine monoclonal antibody (mAB),  
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4G10, was purchased from Upstate Biotechnology (Lake Placid, NY). PNA-
Alexa 488 was purchased from Invitrogen Corp. (Carlsbad, CA). Fetal bovine 
serum (FBS), TCM 199 with Hanks salts, TCM 199 with Earles salts, DMEM/F-
12 and gentamicin were purchased from Gibco (Carlsbad, CA). Follicle 
stimulating hormone (FSH) was purchased from Sioux Biochemical (Sioux 
Center, IA). All other chemicals were from Sigma Chemical Company (St. Louis, 
MO). 
Sperm culture media. Sperm were incubated as previously described [17] 
in modified Whittens (MW; 100 mM NaCl, 4.7 mM KCl, 1.2 mM MgCl2, 5.5 mM 
glucose (anhydrous), 22 mM HEPES, 4.8 mM lactic acid hemicalcium salt and 
1.0 mM pyruvic acid) [36]. Negative control, non-capacitating medium lacked 
BSA and NaHCO3 and also served as transport medium. Capacitating 
conditions were prepared by adding 25 mM NaHCO3 and 7 mg/ml BSA to the 
non-capacitating MW base medium. For both media, the final pH was brought to 
7.25 with HCl.  
Semen collection and preparation. Semen was collected with an artificial 
vagina from six adult stallions of proven fertility in compliance with Institutional 
Animal Care and Use Committee guidelines. After visual evaluation of sperm 
motility under light microscopy on a heated stage and assessment of sperm 
concentration using a 534B MOD1 Densimeter (Animal Reproduction Systems, 
Chino, CA), the sperm-rich fraction was diluted 2:1 (vol:vol) in pre-warmed non-
capacitating MW and transported to the laboratory (10 min) at 37°C for 
immediate processing. Samples were centrifuged in 15-ml conical tubes at 100 
x g for 1 min (37°C) to remove particulate matter and dead sperm. The 
supernatant was then transferred to a 14-ml round-bottom centrifuge tube and 
centrifuged at 600 x g for 5 min (37°C), and resuspended in non-capacitating or  
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capacitating MW to a final concentration of 10 x 10
6 sperm/ml. Samples were 
incubated in 500 μl aliquots in polyvinyl alcohol coated 5-ml round-bottom tubes 
[37] at 37
oC in a humidified air atmosphere. 
Statistical analysis. Data for motility measures (detailed below) were 
analyzed by two-way ANOVA using SigmaStat software (San Jose, CA). Raw 
data for percent acrosome reacted sperm were transformed using arcsin square 
root and then analyzed by two-way ANOVA; raw data for percent hyperactivated 
sperm sorts were also transformed using arcsin square root and then analyzed 
by two-way repeated measures ANOVA. When significant differences were 
detected (P < 0.05) the Student-Newman-Keuls method was applied to assess 
all pairwise multiple comparisons.  
 
Characterization of Hyperactivation in Stallion Sperm: Effects of Procaine on 
Motility Measures Pre- and Post-Capacitation  
Induction of hyperactivation and motility analysis.  Hyperactivation of 
spermatozoa resuspended in capacitating MW was induced with the addition of 
procaine (5 mM final concentration [33]; dissolved in capacitating MW). Sperm 
motility was analyzed at 0 h and after 6 h of incubation under capacitating 
conditions using computer assisted semen analysis (CASA) with an HTM-IVOS 
equipped with a heated stage (version 12, V32.01L; Hamilton Thorne 
Biosciences, Beverly, MA) immediately following the addition of procaine. Eight 
motility parameters were evaluated: % motile, average path velocity (VAP, 
μm/sec, is the average velocity of sperm along the smoothed cell path), straight 
line velocity (VSL, μm/sec, is the average velocity measured in a straight line 
from beginning to end), curvilinear velocity (VCL, μm/sec, is the average rate of 
travel of the sperm head), amplitude of lateral head displacement (ALH, in μm,  
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is the mean width of head oscillations), beat cross frequency (BCF, in Hz, is 
frequency that the head crosses the sperm track), straightness (STR, is 
VSL/VAP x 100) and linearity (LIN is VSL/VCL x 100). Two ejaculates each from 
three stallions were used for data analysis and >200 sperm were analyzed per 
treatment sample.  
After the identification of motility variables for which significant measures 
were indicative of hyperactivation in procaine-treated sperm, the 0 and 6 h 
control conditions were re-analyzed to determine the percentage of 
spontaneously hyperactivated sperm. For this purpose, two sets of parameters 
were compared using the CASA sorting system: (1) VSL ≤ 50.9 μm/sec and LIN 
≤ 20.9% vs (2) VCL ≥ 246.8 μm/sec and LIN ≤ 20.2%. Each field was analyzed 
individually and overlapping and/or agglutinated sperm tracks were not counted. 
Videos of activated and hyperactivated sperm were obtained with a Zeiss 
Axiovert microscope on a 37°C heated stage. Sperm were videotaped using 
Hoffman Modulation Contrast optics at 300x with stroboscopic illumination at 30 
Hz (Strobex, Chadwick-Helmuth Co., El Monte, CA). Images were obtained with 
a black and white video camera (Model CCD72, Dage-MTI, Inc., Michigan City, 
IN) and recorded with an HDD/DVD digital recorder (Lite-On, Fremont, CA).  
 
Effect of Procaine on Tyrosine Phosphorylation and Acrosomal Exocytosis 
SDS-PAGE and immunoblotting. Sperm were incubated in non-
capacitating and capacitating MW for 0, 2, 4 and 6 h in the presence and 
absence of 5 mM procaine. Following incubation, samples were processed for 
SDS-PAGE and immunoblotting as previously described [17]. Briefly, samples 
were washed by centrifugation and the final pellet was resuspended in sample 
buffer [38] containing DTT (40 mM). Samples were then boiled for 5 minutes.  
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The total volume of extract corresponding to equal numbers of sperm in each 
sample (5 x 10
6 sperm) was loaded on 10% SDS gels. Separated proteins were 
blotted onto Immobilon P membranes (Millipore, Inc., Billerica, MA), and blocked 
for 1 h with 1:10 (vol:vol) dilution of cold water fish skin gelatin in TBS-Tween 
20. TBS-Tween 20 was used for all subsequent antibody incubations and 
washes. Immunodetection of tyrosine-phosphorylated proteins was performed 
using a monoclonal antibody against phosphotyrosine at a 1:10,000 dilution for 
1 h, followed by incubation for 30 min with goat anti-mouse horseradish 
peroxidase-coupled IgG. Immunoreactivity was visualized using enhanced 
chemiluminescence detection with an ECL kit (Amhersham Corp., Piscataway, 
NJ) according to the manufacturer‟s directions. Experiment shown is 
representative of three replicates with three different stallions.  
Acrosome reaction assay. Sperm were resuspended in capacitating MW 
for 0 or 6 h. Induction of acrosomal exocytosis was performed by incubating 
sperm for an additional 30 min in the presence of 5 μM calcium ionophore 
A23187 (CaI; [17]), an equal volume of vehicle control (DMSO) or 5 mM 
procaine. Sperm were washed and resuspended in 125 μl of PBS. To evaluate 
acrosomal status of sperm, PNA-Alexa 488 (final concentration 0.024 mg/ml; 
[17]) was added to the sperm suspension and incubated for 5 min in a 37°C 
water bath. The entire suspension was then pipetted onto clean glass slides and 
allowed to settle for 5 min at room temp. The slides were gently washed with 1 
ml PBS (x 2), fixed with 2% paraformaldehyde for 10 min, washed again with 1 
ml PBS (x 3) and mounted with Vectashield (Vector Laboratories, Burlingame, 
CA). Slides were scored (630x) for acrosomal status using an upright 
fluorescent Zeiss Imager ZI microscope (Thornwood, NY) with Green 
Fluorescent Protein (GFP) filters. Two hundred morphologically normal sperm  
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were counted per slide and evaluation was performed blindly of treatment 
status. Sperm were categorized as acrosome intact (post-acrosomal 
fluorescence only), intermediate (fluorescence on the apical ridge of acrosome) 
or acrosome reacted (bright acrosomal fluorescence) as previously described 
[17]. 
 
Effect of Procaine on In Vitro Fertilization  
Oocyte maturation. Equine cumulus-oocyte complexes (COCs) were 
obtained by scraping the follicular wall of ovaries [8] obtained from two different 
sources: (1) abattoir derived (Equine Reproduction Laboratory, Texas A&M 
University); and (2) post-mortem ovaries from the necropsy service at Cornell 
University College of Veterinary Medicine. Abattoir-derived COCs were shipped 
overnight in 1:1 (vol:vol) TCM 199 with Hanks salts and TCM 199 with Earles 
salts, supplemented with 25 µg/ml gentamicin, and 20% fetal bovine serum 
(FBS) at room temperature [39]. Upon arrival to our laboratory or upon retrieval 
from post-mortem ovaries, COCs were transferred to culture dishes in 50 μl 
droplets of maturation medium (TCM 199 with Earles salts supplemented with 
25 µg/ml gentamicin, 10% FBS and 5 mU/ml FSH) under mineral oil and placed 
in an incubator at 38.2°C, with 5% CO2, in a humidified air atmosphere for 24 h. 
After maturation, COCs were partially denuded by gentle mouth pipetting in 
0.05% porcine hyaluronidase diluted in TCM 199 (Hanks salts, 25 µg/ml 
gentamicin, 20% FBS) and evaluated for quality (i.e. smooth plasma membrane 
and apparent perivitelline space). Polar body visualization could not always be 
used as a maturation criterion because the cumulus was not completely 
removed prior to IVF experiments. 
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In vitro fertilization. Sperm were incubated at 10 x 10
6 sperm/ml in 
capacitating MW for 6 h and then diluted to 1 x 10
6 sperm/ml in capacitating MW 
with or without 5 mM procaine. Droplets (100 μl) of the sperm suspensions were 
pipetted onto culture dishes and covered with mineral oil. Five mature partially 
denuded mare oocytes were transferred to each droplet and culture dishes were 
incubated at 38.2°C in 5% CO2 in humidified air. After 18 h of coincubation, 
oocytes were transferred to an embryo culture medium (DMEM/F-12 
supplemented with 25 μg/ml gentamicin and 10% FBS [40]), in 5% CO2/90% N2 
mixed gas atmosphere) for an additional 24 h. Oocytes were then fully denuded 
by mouth pipetting in 0.05% porcine hyaluronidase (as above), fixed in 10% 
buffered formaldehyde with 0.1% Triton X-100 (vol:vol) and mounted onto glass 
slides with 6.5 μl of 9:1 glycerol:PBS containing 2.5 μg/ml Hoechst 33258 to 
assess fertilization status and chromatin configuration. Coverslips were sealed 
and oocytes evaluated on a Nikon Eclipse TE200 inverted microscope (Melville, 
NY) with fluorescent filters. Oocytes were considered fertilized if one or more 
decondensing sperm heads or pronuclei were observed, or if they had cleaved 
to the two-cell stage. Degenerating oocytes containing no chromatin or 
fragmented chromatin, and oocytes that had failed to mature to metaphase II 
were not counted in the assessment of fertilization rates. 
 
RESULTS 
Characterization of Hyperactivation in Stallion Sperm: Effects of Procaine on 
Motility Measures Pre- and Post-Capacitation  
Procaine is a local anesthetic that has been demonstrated to induce 
hyperactivation in sperm from other mammalian species, possibly by increasing 
the plasma membrane‟s permeability to calcium [34]. The addition of procaine (5  
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mM final concentration [33]) to stallion sperm at 0 h elicited an immediate 
change in motility in nearly all motile sperm, characterized by a star-shaped 
movement pattern (Figure 4.1B). Procaine-treated sperm completed more than 
one circle within the measuring period (30 frames at 60 Hz) as depicted by the 
overlap of the sperm track (Figure 4.1B). This change in motility was 
characterized by an increase in ALH (P = 0.013) as well as decreases in STR (P 
= 0.003) and LIN (P = 0.005; Table 1). Because movement of the sperm head is 
dependent on the pattern of flagellum movement, increases in ALH with a 
concomitant decrease in LIN and/or STR are consistent with hyperactivation 
[28]. After 6 h of incubation under capacitating conditions, the motility of control 
sperm was visually similar to that observed at 0 h (Figure 4.1A, C); nonetheless, 
these sperm were slower as detected by decreases in VAP (148.7 μm/sec vs. 
122.6 μm/sec; P = 0.008) and VCL (276.7 μm/sec vs 237.7 μm/sec; P = 0.023; 
Table 2). Treatment with procaine at 6 h of incubation resulted in tracks that 
were shortened and more curved when compared to the non-treated control 
(Figure 4.1C, D). These sperm did not typically complete a full circle, as 
observed in the 0 h procaine-treated condition; however, treatment with 
procaine did elicit decreases in VSL (P = 0.029), STR (P < 0.001) and LIN (P = 
0.002; Table 2), changes consistent with hyperactivation [28]. There were no 
significant interactions between treatment and stallion or ejaculate within the 0 
or 6 h time points. Figure 4.2 depicts still images obtained from videos of control 
and procaine-treated sperm at 0 and 6 h of incubation. Supplemental Movies 1-
4 are available online at www.biolreprod.org. 
Stallion sperm require prolonged incubation to demonstrate markers of 
capacitation such as tyrosine phosphorylation and acrosomal responsiveness 
[17]. In other species it has been demonstrated that without these hallmarks of  
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Table 4.1. CASA measurements before and after the addition of 5 mM procaine to stallion sperm at Time 0 hour.  
_____________________________________________________________________________________________  
Condition           VAP(μm/sec)     VSL(μm/sec)     VCL(μm/sec)     ALH(μm/sec)a    BCF(Hz)     STR(%)b    LIN(%)b__                                            
Cap                     148.7 ± 5.1         89.5 ± 15.4       276.7 ± 7.3           9.4 ± 0.2        41.5 ± 0.9    60.6 ± 3.7   34.5 ± 2.2          
Cap + Procaine   170.0 ± 15.4       66.2 ± 7.7        334.8 ± 25.4         12.8 ± 0.9      40.2  ± 1.3    37.9 ± 2.7   19.8 ± 1.4     
                                          
Data is expressed as ± SEM.  
aValues within columns are significantly different; P = 0.013  
bValues within columns are significantly different;  P ≤ 0.005 
 
 
Table 4.2. CASA measurements before and after the addition of 5 mM procaine to stallion sperm at Time 6 hour.  
______________________________________________________________________________________________ 
Condition         VAP(μm/sec)     VSL(μm/sec)a    VCL(μm/sec)     ALH(μm/sec)     BCF(Hz)       STR(%)b       LIN(%)b__                                       
Cap                     122.6 ± 10.1     69.9 ± 9.1          237.7 ± 15.5       8.8 ± 0.3         40.9 ± 0.7     59.2 ± 4.3     32.1 ± 2.4       
Cap + Procaine  109.3 ± 14.3     46.5 ± 4.4          246.8 ± 23.2        9.8 ± 1.0        43.6 ± 1.0      46.6 ± 2.9     20.2 ± 0.7_    
    
Data is expressed as ± SEM.  
aValues within columns are significantly different;  P < 0.03  
bValues within columns are significantly different;  P ≤ 0.002  
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Figure 4.1. Hyperactivation induced by procaine. Representative motion tracks of control 
sperm at 0 h (A) and 6 h (C), and sperm treated with 5 mM procaine at 0 h (B) and 6 h (D). 
Points on the track represent positions of the head in 30 successive video frames in 0.5 
sec. 
9
8
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capacitation, sperm are fertilization incompetent [10, 41-43]. Therefore, when 
defining sorting thresholds to determine the percentage of sperm that underwent 
spontaneous hyperactivation (i.e. not treated with procaine), we used the 
measures obtained from the 6 h time point described above. For this purpose, 
sperm with VSL ≤ 50.9 μm/sec and LIN ≤ 20.9 μm/sec were considered 
hyperactivated. Based on these parameters, ~26% of sperm at 0 h and ~29% of 
sperm at 6 h were hyperactivated under capacitating conditions. In contrast, 
after treatment with procaine ~73% (P = 0.004) and ~55% (P = 0.013) of sperm 
were hyperactivated at 0 and 6 h, respectively. There were no significant 
differences between stallions or ejaculates at the 0 h time point (P > 0.05); 
however, stallion to stallion variability (P < 0.05) was observed after 6 h of 
incubation. Additionally, to rule out the possibility that changes in these 
parameters were associated with decreased velocities of sperm, a second sort 
was performed using a VCL ≥ 246.8 μm/sec in conjunction with a LIN ≤ 20.2%. 
Differences between procaine and non-procaine treated sperm were again  
observed at 0 and 6 h (P = 0.004 and P = 0.038, respectively). There were no  
significant differences between stallions or ejaculates at either time point with 
these parameters (P > 0.05).  
 
Effect of Procaine on Tyrosine Phosphorylation and Acrosomal Exocytosis 
The signaling pathways that initiate and maintain hyperactivated motility 
are not well defined, but calcium, bicarbonate and cAMP have been 
demonstrated essential for this process [24]. Since similar requirements support 
capacitation, the purpose of this experiment was to rule out whether procaine 
was exerting its effects on sperm motility via the induction of protein tyrosine 
phosphorylation. Therefore, sperm were incubated in non-capacitating and   
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Figure 4.2. Representative images from Supplemental Movies 1-4 
(available online at www.biolreprod.org) of control and hyperactivated 
stallion sperm. (A) Control sperm at 0 h. (B) Procaine-treated sperm at 
0 h. (C) Capacitated sperm at 6 h. (D) Capacitated-procaine treated 
sperm at 6 h. 
 
Figure 4.3. Representative immunoblot of sperm incubated for 4 h in 
non-capacitating (NC) or capacitating (Cap) modified Whittens 
medium with and without the addition of 5 mM procaine (+ Proc) and 
probed with anti-phosphotyrosine antibodies.  
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capacitating media in the presence and absence of 5 mM procaine for 0, 2, 4 
and 6 h. As shown in Figure 4.3, incubation in the presence of procaine did not 
have an effect on protein tyrosine phosphorylation. As reported for bovine 
sperm, our results support the hypothesis that the pathways regulating 
capacitation (acrosomal responsiveness) and hyperactivation are separable and 
independent [20, 33, 34]. 
Because the acrosome reaction is a Ca
2+-dependent exocytotic event 
and procaine may induce hyperactivation by increasing plasma membrane 
permeability to calcium [34], we also wanted to investigate whether the induction 
of hyperactivation with procaine had any effect on acrosomal exocytosis. We 
have previously reported significant rates of calcium ionophore -induced 
acrosomal exocytosis in stallion sperm incubated under capacitating conditions. 
In this experiment, we exposed sperm previously incubated for 0 or 6 h in 
capacitating conditions to 5 μM calcium ionophore A23187, 5 mM procaine, or 
0.5% (vol:vol) DMSO (vehicle control; equal volume) for 30 min to test whether 
procaine can induce acrosomal exocytosis. At 0 h, there were no differences 
observed among any of the treatments (P > 0.05; Figure 4.4A). After 6 h of 
incubation, calcium ionophore induced a significant percentage of acrosome 
reacted sperm as compared to procaine and DMSO-treated sperm (35% vs. 
15.2% and 11.8%, respectively; P < 0.03; Figure 4.4B). There was no difference 
between DMSO controls and procaine treated sperm at 6 h (P > 0.05). There 
were also no significant interactions between treatment and stallion or ejaculate 
in either of the time points analyzed. Altogether, these data suggest that 
procaine-induced hyperactivation of stallion sperm is independent from protein 
tyrosine phosphorylation and acrosomal exocytosis events.  
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Effect of Procaine on In Vitro Fertilization 
The ability of a population of sperm to undergo protein tyrosine phosphorylation 
and induced acrosomal exocytosis is suggestive of capacitation [10, 31, 32, 41, 
44]; however, the most definitive test of capacitation is the ability of sperm to 
fertilize an oocyte. Notably, in vitro fertilization (IVF) has been highly 
unsuccessful in the equine, as evidenced by low fertilization rates (0-33%; [2-8]); 
moreover, these results have not been replicable even within laboratories using 
the same protocols [4-6]. Therefore, we wanted to investigate whether our 
capacitation conditions, which conferred time-dependent increases in protein 
tyrosine phosphorylation and acrosomal responsiveness on sperm, would also 
support IVF of mare oocytes. Additionally, because procaine induced changes 
consistent with hyperactivated motility, we combined our capacitation conditions 
with the addition of procaine at the time of insemination. For these experiments, 
sperm were incubated for 6 h at 10 x 10
6 sperm/ml in capacitation medium, then 
further diluted to 1 x 10
6 sperm/ml in capacitation medium with or without the 
addition of procaine (5 mM final concentration) prior to co-incubation with 
mature equine oocytes. In independent replicates, using semen from two 
stallions, we achieved 54% (7/13), 40% (6/15), 66% (4/6), 84% (11/13), 50% 
(4/8), 66% (4/6) and 84% (11/13) fertilization rates, as evidenced by either 
pronuclear formation or cleavage to the two-cell stage (Figure 4.5A, B). In one 
experiment, potential embryos were further incubated until day 3 post-
insemination in embryo culture medium and 4/6 (66%) had cleaved to the 8-16 
cell stage (Figure 4.5C, D). When sperm were incubated in our capacitation 
conditions but procaine was not added at the time of insemination, no oocytes 
were fertilized (0/66 oocytes; total of five experiments). Following these results, 
we wanted to test whether hyperactivation alone in non-capacitated sperm was  
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sufficient to fertilize oocytes. For this purpose, semen from one of these stallions 
was incubated in non-capacitating or capacitating medium for 6 h and diluted to 
1 x 10
6 sperm/ml plus 5 mM procaine as described. Sperm incubated under 
capacitating conditions in the presence of procaine achieved 40% (2/5) 
fertilization, whereas 0% (0/5) of oocytes were fertilized in the non-capacitating 
MW plus procaine condition. These data support the concept that stallion sperm 
must undergo changes consistent with capacitation (protein tyrosine 
phosphorylation and acrosomal responsiveness) as well as acquire 
hyperactivated motility in order to become fertilization-competent. 
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Figure 4.4. Percentages of acrosomal exocytosis in sperm incubated under 
capacitating conditions and exposed to calcium ionophore A23187 (CaI), 5 
mM procaine, or DMSO (vehicle control) at 0 h (A) and 6 h (B). 
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DISCUSSION 
In this study, we characterized the motility pattern and movement 
measurements associated with hyperactivation in stallion sperm and 
demonstrated that stallion sperm hyperactivation is required for successful 
IVF. Because treatment with procaine was not associated with changes in 
protein tyrosine phosphorylation or the induction of acrosomal exocytosis, it is 
Figure 4.5. Representative in vitro fertilized mare oocytes. (A) Hoechst 33258 
staining showing 2 pronuclei (18 h post IVF); (B) phase contrast microscopy of 
a 2 cell embryo (24 h post IVF); (C & D) light microscopy of 8 cell embryos 
(Day 3). 
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unlikely that procaine facilitated fertilization via a mechanism other than the 
induction of sperm hyperactivation. Moreover, neither incubation of sperm in 
capacitation conditions alone nor treatment of non-capacitated sperm with 
procaine supported IVF in our experiments. Altogether, our results indicate 
that both capacitation and hyperactivation are required for successful IVF in 
the horse. 
The addition of procaine to stallion sperm (both at 0 and 6 h of 
incubation) induced significant changes in the motion parameters that have 
been used to define hyperactivated motility in other species [22, 28, 29, 33, 
45-47]. However, treatment with procaine after 6 h of incubation did not elicit 
as robust a response when compared to non-incubated sperm (Supplemental 
Movies 2, 4); rather, the sperm tracks shortened and became more curved 
(Figure 4.1C,D). Nonetheless, in both cases, decreases in LIN and STR were 
consistent with the acquisition of hyperactivation. Therefore, because only 
sperm incubated for 6 h underwent changes consistent with capacitation, and 
were presumably fertilization-competent, we chose to define hyperactivation 
based on the motion measures observed after procaine treatment of sperm 
incubated for 6 h. Based on these experiments, hyperactivated stallion sperm 
can be defined by a VSL ≤ 46.5 ﾱ 4.4 μm/sec, STR ≤ 46.6 ﾱ 2.9% and LIN ≤ 
20.2 ± 0.7% (Table 2). Notably, the difference between procaine and non-
procaine-treated sperm was not attributed to decreased velocities or 
sluggishness of sperm as these differences were still significant when track 
speed (VCL) was ≥ 246.8 μm/sec. In fact, treatment with procaine increased 
VCL at both 0 and 6 h (Tables 1 & 2). 
Sperm from mouse, human and non-human primates undergo 
hyperactivation when incubated under capacitating conditions [28, 45, 46, 48].  
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Conversely, bull sperm do not undergo spontaneous hyperactivation when 
incubated in conditions supporting capacitation and therefore procaine has 
been used to characterize hyperactivation in this species [33]. Moreover, 
treatment of wild type mouse sperm with procaine induces a pattern of 
hyperactivation similar to that observed under in vitro capacitating conditions 
[49]. In order to ascertain whether stallion sperm undergo spontaneous 
hyperactivation under capacitating conditions, we re-analyzed our data using 
the average + SEM of the variables that defined hyperactivation in procaine-
treated samples (VSL ≤ 50.9 μm/sec and LIN ≤ 20.9%). In this context, we 
determined that only 26% of sperm at 0 h and 29% of sperm at 6 h 
spontaneously hyperactivated under capacitating conditions, whereas 73% 
and 55% of procaine-treated sperm fell within the hyperactivated category, at 
0 and 6 h, respectively (P < 0.05). This suggests that some stallion sperm 
undergo spontaneous hyperactivation, albeit below the critical threshold to 
support fertilization as evidenced by our IVF experiments in which 0% of non-
procaine treated sperm fertilized mare oocytes. Moreover, only ~30–50% of 
stallion sperm in an incubated population are capacitated as determined by 
acrosomal responsiveness [17]. Capacitation and hyperactivation are 
separable and independent events, that is, a particular sperm may be 
hyperactivated but not capacitated and vice versa; therefore, only a small 
percentage of incubated sperm displaying hyperactivated motility are capable 
of fertilizing. Furthermore, based on our visual observations of sperm 
incubated in capacitating conditions, hyperactivation in untreated samples 
appeared to be mostly biphasic: Sperm will circle, become progressive, and 
then circle again. We hypothesize that this on and off motility pattern may 
enable sperm to navigate through the uterine or oviductal milieu. In contrast,  
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treatment with procaine synchronizes hyperactivation ensuring that a larger 
percentage of capacitated sperm are hyperactivated during these IVF 
experiments. Additionally, procaine-treated sperm do not exhibit biphasic 
motility but rather they circle continuously (Supplemental Movies 2, 4), 
perhaps giving the continuous thrust or propulsion needed to penetrate the 
zona pellucida.  
Procaine exerts its effects on sperm motility presumably by increasing 
the permeability of the plasma membrane to calcium [34]. This is supported by 
the failure of procaine to elicit motility changes in bovine sperm incubated in 
calcium-free medium [33]. We have also observed this in stallion sperm (data 
not shown). However, calcium is also a critical component of the pathways 
regulating protein tyrosine phosphorylation and acrosomal exocytosis [50-53]. 
One might argue that procaine facilitated IVF through the activation of these 
pathways. However, as found previously in bovine sperm [33], incubation of 
stallion sperm with procaine did not induce time-dependent increases in 
protein tyrosine phosphorylation (Figure 4.3) nor did it induce acrosomal 
exocytosis (Figure 4.4). These results suggest that capacitation and 
hyperactivation are separable and independent events, as demonstrated in 
bovine sperm [33]. Moreover, this leads us to conclude that procaine facilitated 
IVF via the induction of hyperactivated motility.  
Protocols used for equine IVF have typically mimicked those published 
for the bovine species without investigation into the specific incubation 
conditions required for stallion sperm [2, 5, 6, 54]. Moreover, previous reports 
have not adequately defined incubation conditions that supported time-
dependent increases in protein tyrosine phosphorylation in the absence of 
pharmacological reagents, nor have they correlated these changes with the  
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acquisition of acrosomal responsiveness and/or fertilization potential [12, 55]. 
We have recently reported incubation conditions that support stallion sperm 
capacitation [17]; moreover, such conditions were similar to the requirements 
of murine sperm, which may partially explain the inability to previously 
capacitate stallion sperm in the laboratory. Reported IVF protocols yielding the 
highest fertilization rates (33%) have incubated sperm in the presence of 
calcium ionophore for short periods before co-incubation, which increases 
intracellular calcium levels. While previous thinking about the effect of the 
calcium ionophore in these protocols was that it induced capacitation and/or 
the acrosome reaction, it may have been acting in a similar manner to the 
procaine used in the present study, albeit less efficiently, by inducing 
hyperactivated motility. Fertilization rates with untreated horse sperm are 
essentially 0% [2, 4-7], whereas partial or complete removal of the zona 
pellucida results in high fertilization rates, including polyspermic fertilization 
upwards of 65% [3]. However, the essential relationship of hyperactivated 
motility to fertilization is demonstrated by Catsper-null mice, whose sperm lack 
the ability to hyperactivate, can not penetrate zona-intact oocytes in vitro and 
are infertile as a result [18, 19]. Altogether, these studies and ours suggest 
that the major barrier for successful equine IVF is penetration of the zona 
pellucida; moreover, our results corroborate the findings of oocyte transfer 
studies [8] in that that the failure of sperm to penetrate the zona pellucida of in 
vitro matured oocytes under standard IVF conditions is probably not due to 
premature zona hardening (i.e. cortical granule release).  
Due to the difficulties associated with obtaining mare ovaries in the 
United States (all horse slaughterhouses in this country closed in 2007) and of 
superovulating mares for the recovery of meaningful numbers of oocytes,  
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intracytoplasmic sperm injection (ICSI) may still be the clinical assisted 
reproductive technique of choice in subfertility cases linked to poor semen 
quality or when a valuable mare is euthanized due to medical reasons. 
However, studies comparing IVF with ICSI in other species have 
demonstrated differences in the epigenetic imprinting of genes during 
embryonic development with these techniques [56, 57], which highlights the 
physiological relevance of IVF over ICSI. Therefore, understanding the 
underpinnings of stallion sperm capacitation and hyperactivation as it pertains 
to successful IVF may provide insight into the molecular events surrounding 
fertilization in the equine that can be applied to the improvement of other 
assisted reproduction techniques.  
In summary, in this study, we characterized procaine-induced 
hyperactivation of stallion sperm and demonstrated that induction of 
hyperactivation facilitates fertilization. Most notably, by coupling our capacitating 
conditions with the induction of hyperactivation using procaine, we have 
achieved the novel result of substantial and reproducible percentages of 
fertilized mare oocytes in our IVF experiments. 
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CHAPTER FIVE 
 
SUMMARY AND DISCUSSION OF RESULTS 
 
In several domestic and laboratory species, as well as in humans, 
capacitation can be recapitulated in the laboratory by incubating sperm in a 
defined medium.  Two in vitro markers of capacitation include time-dependent 
increases in protein tyrosine phosphorylation and high rates of agonist-
induced acrosomal exocytosis.  In contrast to other species, capacitation of 
stallion sperm has been extremely difficult to achieve with inconsistent results 
reported between and within laboratories.  Moreover, despite numerous 
attempts, only two foals have ever been produced via in vitro fertilization (IVF) 
technology, both of which were born over fifteen years ago.  Evidence 
suggests that this is ultimately due to the inability to appropriately capacitate 
stallion sperm in the laboratory. 
Therefore, the objectives of this research were to take a molecular 
approach to solving the clinical problem of unsuccessful IVF in this species.  
By taking a basic-science approach to solving the problems associated with 
stallion sperm capacitation, something that had been previously lacking in the 
field, the goal of this research was to translate our findings into the successful 
fertilization of mare oocytes.  For this purpose, we felt it was of importance to 
define and characterize: 1) the incubation conditions that supported 
capacitation of stallion sperm, as evidenced by increases in protein tyrosine 
phosphorylation and agonist-induced acrosomal exocytosis; 2) the molecular 
pathways involved in both of these capacitation-dependent events; 3) the 
motion parameters associated with hyperactivated motility; and 4) the  
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incubation conditions that supported successful in vitro fertilization of mare 
oocytes. 
By first performing a systematic comparison of the incubation media 
reportedly used in stallion sperm capacitation experiments, as well as testing a 
mouse sperm capacitation medium, we determined that incubation of stallion 
sperm in the mouse sperm medium modified Whitten‟s was superior to the 
media currently being used in the literature (i.e. SpTALP and BWW).  
Additionally, while optimizing the media requirements, we evaluated the key 
individual components in modified Whitten‟s and concluded that the addition of 
25 mM sodium bicarbonate and 7 mg/ml BSA supported significant time-
dependent increases in protein tyrosine phosphorylation and significant 
percentages of progesterone-induced acrosomal exocytosis.  This research is 
the first demonstration of incubation conditions that support longevity of 
motility (Table 2.1), significant increases in time-dependent protein tyrosine 
phosphorylation (Figure 2.1), and significant percentages of progesterone-
induced acrosomal exocytosis (Figure 2.8). Another major breakthrough in this 
study was the ability to achieve these markers of capacitation in the absence 
of exogenous signaling intermediates (i.e. cAMP analogues) that in other 
reports have bypassed upstream signaling events.  As a result, these 
incubation conditions are considered physiologically relevant for the 
understanding of sperm capacitation in the stallion. 
We hypothesize that modified Whitten‟s supports stallion sperm 
capacitation more effectively than the other media tested because stallion 
sperm may be more similar in their metabolism to mouse sperm than to bovine 
sperm.  For example, mouse sperm utilize glycolysis, and as such, modified 
Whitten‟s contains glucose as the primary energy source.  Bovine sperm  
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utilize oxidative phosphorylation to generate ATP; in fact, glucose inhibits 
capacitation in this species, and as such, the capacitation media contain 
lactate and pyruvate as energy sources.  This difference in sperm physiology 
could account for the previous lack of success in stallion sperm capacitation. 
Through the systematic evaluation of the protein tyrosine 
phosphorylation pathway, we demonstrated that the generation of cAMP via 
SACY was required for this event (Figure 3.1) and that the downstream target 
in this pathway is the serine/threonine kinase protein kinase A (PKA) (Figure 
3.2).  We also investigated the possible role of an alternative cAMP target in 
sperm, the guanine nucleotide exchange factor EPAC.  We were surprised to 
find that EPAC activation had no effect on tyrosine phosphorylation (Figure 
3.6), as it has been demonstrated to activate the MAPK pathway in somatic 
cells.  However, due to the fact the EPAC activation can mobilize calcium 
release, it is involved in exocytotic events in excitable somatic cell types and it 
is present in the acrosome of stallion and mouse sperm, we hypothesized that 
it might play a role in acrosomal exocytosis.  Indeed, the activation of EPAC 
with the EPAC-specific cAMP analog 8pCPT induced significant percentages 
of acrosomal exocytosis in both capacitated stallion and mouse sperm as 
compared to DMSO controls (Figure 3.7).   
Probing deeper into this phenomenon, we demonstrated that when 
sperm were incubated under capacitating conditions in the presence of 
8pCPT, sperm plasma membrane potential was maintained in the depolarized 
state ( - 32 mV) as compared to capacitated sperm, which hyperpolarized (- 54 
mV).  This EPAC-induced depolarization was comparable to non-capacitated 
sperm, which were also depolarized (- 37 mV) (Figure 3.8).  Collectively, these 
data lead us to the following two-part model of stallion sperm capacitation as it  
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pertains to protein tyrosine phosphorylation and acrosomal exocytosis (Figure 
5.1).  
The first part of the capacitation model, as it pertains to protein tyrosine 
phosphorylation, is considered the „early stage‟ of capacitation.  This involves 
changes in plasma membrane fluidity, which are postulated to occur as a 
result of sterol efflux from the plasma membrane; in this regard BSA is used 
as a sterol acceptor during in vitro incubations. These changes then impact 
enzymatic function and/or ion transport.  For example, calcium and 
bicarbonate enter the cell and activate soluble adenylyl cyclase (sAC or 
SACY), amongst other functions, with a resulting increase in intracellular 
cAMP levels.  Altogether, these events lead to an increase in PKA activity, 
which is then transduced into a series of protein tyrosine phosphorylation 
events. 
The second part of the capacitation model, or the „late stage‟ of 
capacitation, involves both PKA and EPAC impacting ion channels in various 
ways resulting in agonist-induced acrosomal exocytosis.  In the non-
capacitated state, a depolarized resting membrane potential of ~ -37 mV is 
observed.  During capacitation, however, cAMP-dependent PKA 
phosphorylates the cystic fibrosis transmembrane conductor (CFTR), thus 
opening this channel and allowing for the influx of Cl
- ions; additionally, 
activation of CFTR inhibits epithelium sodium ion channels (ENaC).  The 
increase of intracellular pH (pHi) that also accompanies capacitation, switches 
the potassium ATP (K
+
ATP) channel from an inwardly rectifying channel to an 
outwardly rectifying channel.  As a result, capacitated sperm have a 
hyperpolarized membrane potential of ~ -54 mV.  This hyperpolarization 
allows for the recruitment of low voltage activated T-Type calcium channels  
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(LVA), which can now be opened upon proper stimulation. We hypothesize 
that when a capacitated sperm contacts the zona pellucida of an oocyte, 
cAMP-dependent EPAC is activated, which in turn inhibits CFTR, allowing 
ENaC channels to become constitutively active again.  Evidence also 
suggests that activation of EPAC inhibits K
+
ATP channels.  Collectively, this 
results in a rapid depolarization of the plasma membrane (~ -32 mV), the 
opening of LVA channels, and the resulting Ca
2+ influx triggers acrosomal 
exocytosis. 
Capacitation and hyperactivation are separable and independent 
events; that is, a particular sperm may be hyperactivated but not capacitated 
and vice versa; therefore, only a small percentage of incubated sperm 
displaying hyperactivated motility are capable of fertilizing, as both are 
required for this event.  Sperm from mouse, human and non-human primates 
undergo hyperactivation when incubated under capacitating conditions, 
whereas bull sperm do not.  Therefore procaine has been used to characterize 
hyperactivation in this species. Additionally, treatment of wild type mouse 
sperm with procaine induces a pattern of hyperactivation similar to that 
observed under in vitro capacitating conditions.  In order to ascertain whether 
stallion sperm undergo spontaneous hyperactivation under capacitating 
conditions, we re-analyzed our data using the average + SEM of the variables 
that defined hyperactivation in procaine-treated samples (VSL ≤ 50.9 μm/sec 
and LIN ≤ 20.9%). In this context, we determined that only 26% of sperm at 0 
h and 29% of sperm at 6 h spontaneously hyperactivated under capacitating 
conditions, whereas 73% and 55% of procaine-treated sperm fell within the 
hyperactivated category, at 0 and 6 h, respectively (P < 0.05).  This suggests 
that some stallion sperm undergo spontaneous hyperactivation, albeit below   
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Figure 5.1. Postulated pathways leading to capacitation-dependent increases 
in protein tyrosine phosphorylation, plasma membrane hyerpolarization and 
acrosomal exocytosis. BSA: bovine serum albumin; HCO3
-: sodium 
bicarbonate; sAC: soluble adenylyl cyclase; PDE: phosphodiesterase; PKA: 
protein kinase A; PTK: protein tyrosine kinases; Ptyr-Ptase: protein tyrosine 
phosphatases; AKAP: A-kinase anchoring protein; pHi: intracellular pH; CFTR: 
cystic fibrosis transmembrane conductor; ENaC: epithelium sodium ion 
channel; K
+
ATP: potassium ATP channel; EPAC: guanine-nucleotide exchange 
factor; LVA: low voltage activated T-Type calcium channel.  See text for 
pathway details.  
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the critical threshold to support fertilization as evidenced by our IVF 
experiments in which 0% of non-procaine treated sperm fertilized mare 
oocytes. Moreover, only ~30–50% of stallion sperm in an incubated population 
are capacitated as determined by acrosomal responsiveness.   
Furthermore, based on our visual observations of sperm incubated in 
capacitating conditions, hyperactivation in untreated samples appeared to be 
mostly biphasic: Sperm will circle, become progressive, and then circle again. 
We hypothesize that this on and off motility pattern may enable sperm to 
navigate through the uterine or oviductal milieu. In contrast, treatment with 
procaine synchronizes hyperactivation ensuring that a larger percentage of 
capacitated sperm are hyperactivated during our IVF experiments. 
Additionally, procaine-treated sperm do not exhibit biphasic motility but rather 
they circle continuously, perhaps giving the continuous thrust or propulsion 
needed to penetrate the zona pellucida.  
  By characterizing the motion parameters associated with procaine-
induced hyperactivation in stallion sperm in juxtaposition with our capacitating 
conditions, we were able to achieve the highest rates of homologous in vitro 
fertilization reported in this species (60.7% vs. 0-30% previously reported). 
These findings were therefore critical in determining the incubation conditions 
that support successful IVF in the horse. 
Collectively, these studies demonstrate newly defined incubation 
conditions for capacitation and in vitro fertilization in the horse, as well as 
contribute to our understanding of the pathways governing these events in 
mammalian sperm.   
 